Veröffentlichungen

Publikationsverzeichnis Prof. Dr. Peter Kienle

1Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score.
COVIDSurg Collaborative.Br J Surg. 2021 Nov 11;108(11):1274-1292. doi: 10.1093/bjs/znab183.PMID: 34227657 Free PMC article.

Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004.
Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignaß A, Ehehalt R, Germer C, Grunert PC, Helwig U, Herrlinger K, Kienle P, Kreis ME, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators:.Z Gastroenterol. 2022 Mar;60(3):332-418. doi: 10.1055/a-1713-3941. Epub 2022 Mar 9.PMID: 35263784 German. No abstract available.

CED – individualisierte Diagnostik und Therapie.
Arlt G, Kienle P.Zentralbl Chir. 2021 Oct;146(5):433-437. doi: 10.1055/a-1209-5935. Epub 2021 Oct 19.PMID: 34666353 German. No abstract available.

Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline.
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:.Z Gastroenterol. 2020 Dec;58(12):e241-e326. doi: 10.1055/a-1296-3444. Epub 2020 Dec 1.PMID: 33260237 German. No abstract available.

[Transanal total mesorectal excision-a critical appraisal].
Holmer C, Benz S, Fichtner-Feigl S, Jehle EC, Kienle P, Post S, Schiedeck T, Weitz J, Kreis ME.Chirurg. 2019 Jun;90(6):478-486. doi: 10.1007/s00104-019-0945-x.PMID: 30911795 Review. German.

[A rare cause of small-bowel perforation].
Saifi M, Kienle P.Chirurgie (Heidelb). 2022 Sep;93(9):899-901. doi: 10.1007/s00104-022-01640-9. Epub 2022 Apr 11.PMID: 35403908 German. No abstract available.

Predictors for Anastomotic Leak, Postoperative Complications, and Mortality After Right Colectomy for Cancer: Results From an International Snapshot Audit.
2015 European Society of Coloproctology Collaborating Group.Dis Colon Rectum. 2020 May;63(5):606-618. doi: 10.1097/DCR.0000000000001590.PMID: 32032201

Reducing Perioperative Risks of Surgery in Crohn's Disease.
Reindl W, Thomann AK, Galata C, Kienle P.Visc Med. 2019 Dec;35(6):348-354. doi: 10.1159/000504030. Epub 2019 Nov 12.PMID: 31934582 Free PMC article. Review.

[TaTME is an experimental procedure].
Holmer C, Benz S, Fichtner-Feigl S, Jehle EC, Kienle P, Post S, Schiedeck T, Weitz J, Kreis ME.Chirurg. 2019 Jun;90(6):489-492. doi: 10.1007/s00104-019-0979-0.PMID: 31127334 German. No abstract available.

[August 2019 - AWMF-Registriernummer: 021-009].
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:.Z Gastroenterol. 2019 Nov;57(11):1321-1405. doi: 10.1055/a-1015-7265. Epub 2019 Nov 18.PMID: 31739378 German. No abstract available.

Impact of Modern Drug Therapy on Surgery: Crohn's Disease.
Kienle P.Visc Med. 2018 Dec;34(6):422-425. doi: 10.1159/000495127. Epub 2018 Nov 30.PMID: 30675486 Free PMC article. Review.

[August 2019 - AWMF-Registriernummer: 021-009].
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:.Z Gastroenterol. 2019 Nov;57(11):e1. doi: 10.1055/a-1108-3778. Epub 2020 Feb 18.PMID: 32069500 German. No abstract available.
[Chronic anastomotic leak after low rectal resection-an unsolved problem?].
Kienle P, Magdeburg JR.Chirurg. 2021 Jul;92(7):605-611. doi: 10.1007/s00104-021-01400-1. Epub 2021 Apr 14.PMID: 33852017 Review. German.
Checkpoint Inhibitor-Induced Colitis-A Clinical Overview of Incidence, Prognostic Implications and Extension of Current Treatment Options.
Portenkirchner C, Kienle P, Horisberger K.Pharmaceuticals (Basel). 2021 Apr 16;14(4):367. doi: 10.3390/ph14040367.PMID: 33923423 Free PMC article. Review.

Molecular characterization of ulcerative colitis-associated colorectal carcinomas.
Hirsch D, Hardt J, Sauer C, Heselmeyer-Hadded K, Witt SH, Kienle P, Ried T, Gaiser T.Mod Pathol. 2021 Jun;34(6):1153-1166. doi: 10.1038/s41379-020-00722-5. Epub 2020 Dec 14.PMID: 33318582 Free PMC article.

[Updated S3-Guideline Colitis ulcerosa. German Society for Digestive and Metabolic Diseases (DGVS) - AWMF Registry 021/009].
Authors; Collaborators:.Z Gastroenterol. 2018 Sep;56(9):1087-1169. doi: 10.1055/a-0651-8174. Epub 2018 Sep 11.PMID: 30206914 Free article. German.

[Minimally invasive and robot-assisted surgery for chronic inflammatory bowel disease : Current status and evidence situation].
Kienle P, Magdeburg R.Chirurg. 2021 Jan;92(1):21-29. doi: 10.1007/s00104-020-01306-4.PMID: 33274393 Review. German.

[Standardization of preoperative locoregional staging in rectal cancer with MRI].
Stelzner S, Fichtner-Feigl S, Kahlke V, Kienle P, Kroesen A, Grenacher L, Wessling J.Chirurg. 2021 May;92(5):482-484. doi: 10.1007/s00104-021-01411-y. Epub 2021 Apr 28.PMID: 33909106 German. No abstract available.

Flexible endoscopy is enough diagnostic prior to loop ileostomy reversal.
Lindner S, von Rudno K, Gawlitza J, Hardt J, Sandra-Petrescu F, Seyfried S, Kienle P, Reissfelder C, Bogner A, Herrle F.Int J Colorectal Dis. 2021 Feb;36(2):413-417. doi: 10.1007/s00384-020-03766-w. Epub 2020 Oct 13.PMID: 33048240 Free PMC article.

Association of ileocolic pedicle division with postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis for ulcerative colitis.
Tzatzarakis E, Herrle F, Reindl W, Altmayer N, Minas D, Kienle P, Reissfelder C, Şandra-Petrescu F.BMC Surg. 2021 Dec 18;21(1):426. doi: 10.1186/s12893-021-01428-4.PMID: 34922520 Free PMC article.

Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.
Hirsch D, Wangsa D, Zhu YJ, Hu Y, Edelman DC, Meltzer PS, Heselmeyer-Haddad K, Ott C, Kienle P, Galata C, Horisberger K, Ried T, Gaiser T.Clin Cancer Res. 2018 Oct 15;24(20):4997-5011. doi: 10.1158/1078-0432.CCR-18-0630. Epub 2018 Jul 2.PMID: 29967250 Free PMC article.

Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS).
Authors; Collaborators:.Z Gastroenterol. 2019 Feb;57(2):162-241. doi: 10.1055/a-0824-0861. Epub 2019 Jan 17.PMID: 30654406 English.

[Position paper on reporting of intestinal ultrasound findings in patients with inflammatory bowel disease].
Kucharzik T, Atreya R, Bachmann O, Baumgart DC, Daebritz J, Helwig U, Janschek J, Kienle P, Langhorst J, Mudter J, Schmidt C, Schreyer AG, Vieth M, Wessling J, Maaser C.Z Gastroenterol. 2022 Jun;60(6):978-990. doi: 10.1055/a-1801-0170. Epub 2022 Jun 7.PMID: 35671995 German.

Clinical and Histopathologic Features of Colorectal Adenocarcinoma in Crohn's Disease.
Galata C, Hirsch D, Reindl W, Post S, Kienle P, Boutros M, Gaiser T, Horisberger K.J Clin Gastroenterol. 2018 Aug;52(7):635-640. doi: 10.1097/MCG.0000000000000817.PMID: 28654553 Free article.

Patients with Crohn's disease have longer post-operative in-hospital stay than patients with colon cancer but no difference in complications' rate.
2015 European Society of Coloproctology (ESCP) collaborating group.World J Gastrointest Surg. 2019 May 27;11(5):261-270. doi: 10.4240/wjgs.v11.i5.261.PMID: 31171957 Free PMC article.

How to reduce anastomotic leakage in colorectal surgery-report from German expert meeting.
Rink AD, Kienle P, Aigner F, Ulrich A.Langenbecks Arch Surg. 2020 Mar;405(2):223-232. doi: 10.1007/s00423-020-01864-5. Epub 2020 Mar 18.PMID: 32189067

Height of Rectal Cancer: A Comparison between Rectoscopic and Different MRI Measurements.
Attenberger UI, Winter J, Harder FN, Burkholder I, Dinter D, Kaltschmidt S, Kienle P, Schoenberg SO, Hofheinz R.Gastroenterol Res Pract. 2020 Jan 28;2020:2130705. doi: 10.1155/2020/2130705. eCollection 2020.PMID: 32411193 Free PMC article.

Clinical, oncological, and functional outcomes of Da Vinci (Xi)-assisted versus conventional laparoscopic resection for rectal cancer: a prospective, controlled cohort study of 51 consecutive cases.
Galata C, Vassilev G, Haas F, Kienle P, Büttner S, Reißfelder C, Hardt J.Int J Colorectal Dis. 2019 Nov;34(11):1907-1914. doi: 10.1007/s00384-019-03397-w. Epub 2019 Oct 23.PMID: 31642968 Clinical Trial.

Indocyanine Green Tissue Angiography Can Reduce Extended Bowel Resections in Acute Mesenteric Ischemia.
Karampinis I, Keese M, Jakob J, Stasiunaitis V, Gerken A, Attenberger U, Post S, Kienle P, Nowak K.J Gastrointest Surg. 2018 Dec;22(12):2117-2124. doi: 10.1007/s11605-018-3855-1. Epub 2018 Jul 10.PMID: 29992520

Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
Stallmach A, Sturm A, Blumenstein I, Helwig U, Koletzko S, Lynen P, Schmidt C, Dignass A, Kucharzik T; Collaborators:.Z Gastroenterol. 2020 Oct;58(10):982-1002. doi: 10.1055/a-1234-8079. Epub 2020 Oct 9.PMID: 33036052 English.

Lateral pararectal versus transrectal stoma placement for prevention of parastomal herniation.
Hardt J, Meerpohl JJ, Metzendorf MI, Kienle P, Post S, Herrle F.Cochrane Database Syst Rev. 2019 Apr 24;4(4):CD009487. doi: 10.1002/14651858.CD009487.pub3.PMID: 31016723 Free PMC article.

Clinical outcome and quality of life after gracilis muscle transposition for fistula closure over a 10-year period.
Grott M, Rickert A, Hetjens S, Kienle P.Int J Colorectal Dis. 2021 Mar;36(3):569-580. doi: 10.1007/s00384-020-03825-2. Epub 2021 Jan 2.PMID: 33386945

Reliability of neural food cue-reactivity in participants with obesity undergoing bariatric surgery: a 26-week longitudinal fMRI study.
Bach P, Grosshans M, Koopmann A, Kienle P, Vassilev G, Otto M, Bumb JM, Kiefer F.Eur Arch Psychiatry Clin Neurosci. 2021 Aug;271(5):951-962. doi: 10.1007/s00406-020-01218-8. Epub 2020 Dec 17.PMID: 33331960 Free PMC article.

An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
2017 European Society of Coloproctology (ESCP) collaborating group.Colorectal Dis. 2018 Sep;20 Suppl 6:33-46. doi: 10.1111/codi.14376.PMID: 30255642

Safety of primary anastomosis following emergency left sided colorectal resection: an international, multi-centre prospective audit.
2017 European Society of Coloproctology (ESCP) collaborating group.Colorectal Dis. 2018 Sep;20 Suppl 6:47-57. doi: 10.1111/codi.14373.PMID: 30255647

Extensive intraperitoneal lavage to eliminate intraperitoneal tumor cells in gastrectomy with D2 lymphadenectomy for gastric cancer.
Ronellenfitsch U, Ernst K, Mertens C, Trunk MJ, Ströbel P, Marx A, Kienle P, Post S, Nowak K.Tumori. 2018 Oct;104(5):361-368. doi: 10.1177/0300891618792485. Epub 2018 Sep 5.PMID: 30185117

Predictors of weight loss in participants with obesity following bariatric surgery - A prospective longitudinal fMRI study.
Bach P, Grosshans M, Koopmann A, Pfeifer AM, Vollstädt-Klein S, Otto M, Kienle P, Bumb JM, Kiefer F.Appetite. 2021 Aug 1;163:105237. doi: 10.1016/j.appet.2021.105237. Epub 2021 Mar 29.PMID: 33794259

[Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers].
Stallmach A, Sturm A, Blumenstein I, Helwig U, Koletzko S, Lynen P, Schmidt C, Dignaß A, Kucharzik T; Collaborators:.Z Gastroenterol. 2020 Jul;58(7):672-692. doi: 10.1055/a-1193-5475. Epub 2020 Jul 13.PMID: 32659830 Free PMC article. German.

KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.
Schmitz D, Kazdal D, Allgäuer M, Trunk M, Vornhusen S, Nahm AM, Doll M, Weingärtner S, Endris V, Penzel R, Kirchner M, Brandt R, Neumann O, Sültmann H, Budczies J, Kienle P, Magdeburg R, Hetjens S, Schirmacher P, Bergmann F, Rudi J, Stenzinger A, Volckmar AL.Genes Chromosomes Cancer. 2021 Jul;60(7):489-497. doi: 10.1002/gcc.22946. Epub 2021 Mar 16.PMID: 33686791

The impact of stapling technique and surgeon specialism on anastomotic failure after right-sided colorectal resection: an international multicentre, prospective audit.
2015 European Society of Coloproctology Collaborating Group.Colorectal Dis. 2018 Nov;20(11):1028-1040. doi: 10.1111/codi.14308. Epub 2018 Jul 12.PMID: 29920945 Free article.

Impact of adjuvant chemotherapy on patients with ypT0-2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital.
Galata C, Merx K, Mai S, Gaiser T, Wenz F, Post S, Kienle P, Hofheinz RD, Horisberger K.World J Surg Oncol. 2018 Aug 2;16(1):156. doi: 10.1186/s12957-018-1455-x.PMID: 30071852 Free PMC article.

Laparoscopic ventral pouch pexy with acellular dermal matrix (ADM)-a novel technique for the treatment of full-thickness pouch prolapse after restorative proctocolectomy and j-pouch.
Hardt J, Kienle P.Int J Colorectal Dis. 2018 Nov;33(11):1643-1646. doi: 10.1007/s00384-018-3135-2. Epub 2018 Jul 21.PMID: 30032453

Risk factors for early postoperative complications and length of hospital stay in ileocecal resection and right hemicolectomy for Crohn's disease: a single-center experience.
Galata C, Weiss C, Hardt J, Seyfried S, Post S, Kienle P, Horisberger K.Int J Colorectal Dis. 2018 Jul;33(7):937-945. doi: 10.1007/s00384-018-3072-0. Epub 2018 May 7.PMID: 29736773

Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery.
2017 European Society of Coloproctology (ESCP) collaborating group.Colorectal Dis. 2018 Sep;20 Suppl 6:58-68. doi: 10.1111/codi.14361.PMID: 30255641

[Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers].
Stallmach A, Sturm A, Blumenstein I, Helwig U, Koletzko S, Lynen P, Schmidt C, Dignaß A, Kucharzik T; Collaborators:.Z Gastroenterol. 2020 Jul;58(7):e367. doi: 10.1055/a-1375-6282. Epub 2021 Feb 5.PMID: 33545734 Free PMC article. German. No abstract available.

Incisional hernia rate after ileostomy closure in lateral pararectal stoma versus transrectal stoma placement: follow-up of the randomized PATRASTOM trial.
Seyfried S, Lucas V, Galata C, Reißfelder C, Weiß C, Kienle P, Hardt J.Colorectal Dis. 2020 Apr;22(4):445-451. doi: 10.1111/codi.14887. Epub 2019 Nov 12.PMID: 31652025 Clinical Trial.

The impact of conversion on the risk of major complication following laparoscopic colonic surgery: an international, multicentre prospective audit.
2017 and 2015 European Society of Coloproctology (ESCP) collaborating groups.Colorectal Dis. 2018 Sep;20 Suppl 6:69-89. doi: 10.1111/codi.14371.PMID: 30255643

Risk factors for early postoperative complications in patients with Crohn's disease after colorectal surgery other than ileocecal resection or right hemicolectomy.
Galata C, Kienle P, Weiss C, Seyfried S, Reißfelder C, Hardt J.Int J Colorectal Dis. 2019 Feb;34(2):293-300. doi: 10.1007/s00384-018-3196-2. Epub 2018 Nov 20.PMID: 30460473

Gallbladder Cancer Presenting as Mirizzi Syndrome Complicated by Rapidly Evolving 23 rRNA Gene-Linezolid Resistance with Vancomycin-Resistant Enterococcus Infection Resulting in Fatal Cholangial Sepsis.
Schmitz D, Eigner U, Schmidt-Wieland T, Weber P, Magdeburg R, Kienle P, Rudi J.Case Rep Gastroenterol. 2020 Oct 28;14(3):540-546. doi: 10.1159/000508851. eCollection 2020 Sep-Dec.PMID: 33250695 Free PMC article.

Association of mechanical bowel preparation with oral antibiotics and anastomotic leak following left sided colorectal resection: an international, multi-centre, prospective audit.
2017 European Society of Coloproctology (ESCP) collaborating group.Colorectal Dis. 2018 Sep;20 Suppl 6:15-32. doi: 10.1111/codi.14362.PMID: 30255646

[The Kono-S anastomosis in surgery for Crohn's disease : First results of a new functional end-to-end anastomotic technique after intestinal resection in patients with Crohn's disease in Germany]. Seyfried S, Post S, Kienle P, Galata CL.Chirurg. 2019 Feb;90(2):131-136. doi: 10.1007/s00104-018-0668-4.PMID: 29931381 German.

Publikationen

• Menz W., Pathophysiologie und Behandlung kardiovaskulärer Erkrankungen. 2. Koronare Herzkrankheit. PZ Prisma 1997, 4: 5-12;
• Litzinger A. und Schweitzer E., Neue Wege einer intensivierten pharmazeutischen Betreuung. Krankenhauspharmazie 1998, 1: 9-13;
• Menz W., AT1-Rezeptorantagonisten, Vergleichende Darstellung einer neuen Arzneimittelklasse zur Therapie des Bluthochdrucks - Teil 1. PZ Prisma 1999, 6: 35-41;
• Menz W., AT1-Rezeptorantagonisten, Vergleichende Darstellung einer neuen Arzneimittelklasse zur Therapie des Bluthochdrucks - Teil 2. PZ Prisma 1999, 6: 90-96;
• Holzschuh G., Litzinger A. und Schweitzer E., Arzneimittelvorrat auf Station ist Sache der Apotheke. Die Schwester Der Pfleger 1999, 6: 472-475;
• •Menz W., ACE-Hemmer in der Kitteltasche. Krankenhauspharmazie 2000, 8: 427-431;
• Menz W. und Schweitzer E., Glykoprotein-IIb/IIIa-Rezeptorantagonisten bei akutem Koronarsyndrom. Teil 1: Grundlagen; Krankenhauspharmazie 2003, 6: 226-231;
• Menz W. und Schweitzer E., Glykoprotein-IIb/IIIa-Rezeptorantagonisten bei akutem Koronarsyndrom. Teil 2: Klinische Studien mit Tirofiban und Eptifibatid; Krankenhauspharmazie 2003, 9: 357-366;
• Menz W. und Schweitzer E., Glykoprotein-IIb/IIIa-Rezeptorantagonisten bei akutem Koronarsyndrom. Teil 3: Klinische Studien mit Abciximab; Krankenhauspharmazie 2003, 10: 411-424;
• Menz W., AABG: Preisgünstige Therapiealternativen nach § 115c SGB V, ACE-Hemmstoffe. Krankenhauspharmazie 2003, 11: 462-469;
• Menz W., ACE-Hemmstoffe, AABG: Preisgünstige Therapiealternativen nach § 115c SGB V. Arzneimitteltherapie 2005, 23: 157-164;
• Menz, W., AABG: Preisgünstige Therapiealternativen nach § 115c SGB V, Insuline. Krankenhauspharmazie 2006, 27: 93-102;
• Litzinger A. und Schweitzer E., 10 Jahre Mannheimer Modell im Theresienkrankenhaus. Krankenhauspharmazie 2006, 27: 267-270;
• Menz, W., Insuline, Ein Vergleich der handelsüblichen Präparate. Medizinische Monatsschrift für Pharmazeuten 2006, 29: 97-100;
• Menz, W., Insuline, AABG: Preisgünstige Therapiealternativen nach § 115c SGB V. Arzneimitteltherapie 2006, 24: 187-196;
• Menz W., Die Beurteilung der Nierenfunktion bei Erwachsenen. PZ Prisma 2008, 1: 13-20;
• Menz W: Insulin. In: Krämer I, Jelkmann W: Rekombinante Arzneimittel - Medizinischer Fortschritt durch Biotechnologie, 2. Auflage, Springer Verlag Berlin Heidelberg 2011, S.61-71.
• Menz W., Aktuelle Marktübersicht der Insulinzubereitungen in Deutschland. Krankenhauspharmazie 2014, 10: 371-375.

Posterpräsentationen

• Litzinger A., Schweitzer E., Mildenberger S., Niedermolekulare Heparine in Multidose-Injektionsflaschen: Was bringt die Umstellung? Vorgestellt beim 28. wissenschaftlichen Kongress der ADKA e.V. in Köln 2000;
• Schweitzer E., Litzinger A., Ellmann T., Bauer G., Management von Notfallarzneimitteln am Beispiel von Präparaten zur HIV-Prophylaxe. Vorgestellt bei der 8. Fachtagung der ADKA e.V. in Mannheim 2001;
• Litzinger A. und Schweitzer E., Ellmann B., Erfassung und Dokumentation resistenter Keime nach Infektionsschutzgesetz. Klinisch-mikrobiologische Serviceleistungen der Krankenhausapotheke. Vorgestellt bei der 8. Fachtagung der ADKA e.V. in Mannheim 2001;
• Reich C.D., Schweitzer E., Pharmazeutische Interventionen bei Patienten mit Niereninsuffizienz auf der Gefäßchirurgie. Vorgestellt beim 32. wissenschaftlichen Kongress der ADKA e.V. in Weimar 2007;
• Klump B., Reich C.D., Menz W., Schweitzer E., Projekt "Zentrale Arzneimittelaufnahme" (Februar - Dezember 2009). Vorgestellt beim 35. wissenschaftlichen Kongress der ADKA e.V. in Freiburg 2010.

• Spezielle gastroenterologische Onkologie im Alter. Rudi J. In: Geriatrische Gastroenterologie Mayet W-J (Hrsg.) 2022; 252-285 Walter de Gruyter Berlin / Boston
• Geriatrische gastrointestinale Onkologie: Ösophagus, Magen, Dickdarm. Rudi J. in Gastroenterologe 2021;16:369-377
• Percutaneous transhepatic or endoscopic ultrasound-guided biliary drainage in malignant distal bile duct obstruction using a self-expanding metal stent: Study protocol for a prospective European multicenter trial (PUMa trial). Schmitz D, Valiente CT, Dollhopf M, Perez-Miranda M, Küllmer A, Gornals J, Vila J, Weigt J, Voigtländer T, Redondo-Cerezo E, von Hahn T, Albert J, Vom Dahl S, Beyna T, Hartmann D, Franck F, García-Alonso FJ, Schmidt A, Garcia-Sumalla A, Arrubla A, Joerdens M, Kleemann T, Tomo JRA, Grassmann F, Rudi J. PLoS One. 2022 Oct 27;17(10):e0275029.
• KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas. Schmitz D, Kazdal D, Allgäuer M, Trunk M, Vornhusen S, Nahm AM, Doll M, Weingärtner S, Endris V, Penzel R, Kirchner M, Brandt R, Neumann O, Sültmann H, Budczies J, Kienle P, Magdeburg R, Hetjens S, Schirmacher P, Bergmann F, Rudi J, Stenzinger A, Volckmar AL.Genes Chromosomes Cancer. 2021 Jul;60(7):489-497.
• Hemosuccus pancreaticus due to a small arterial pseudoaneurysm detected by CE-EUS and successfully treated with angiographic coiling (with video). Schmitz D, Hansmann J, Rudi J. Endosc Ultrasound. 2021 Nov-Dec;10(6):476-478.
• Gallbladder Cancer Presenting as Mirizzi Syndrome Complicated by Rapidly Evolving 23 rRNA Gene-Linezolid Resistance with Vancomycin-Resistant Enterococcus Infection Resulting in Fatal Cholangial Sepsis. Schmitz D, Eigner U, Schmidt-Wieland T, Weber P, Magdeburg R, Kienle P, Rudi J. Case Rep Gastroenterol. 2020 Oct 28;14(3):540-546.
• Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review. Schmitz D, Chang DH, Rudi J, Hetjens S, Ebert MPA. Can J Gastroenterol Hepatol. 2020 Oct 1;2020:8849284.
• Is insertion of a plastic stent better and safer than epinephrine injection in post sphincterotomy bleeding? Schmitz D, Weller N, Doll M, Werle S, Mees C, Prinz P, John B, Schmidt D, Günther A, Weiß C, Rudi J. Eur J Gastroenterol Hepatol. 2020 Apr;32(4):484-489.
• Patient radiation dose in percutaneous biliary interventions: recommendations for DRLs on the basis of a multicentre study. Schmitz D, Vogl T, Nour-Eldin NA, Radeleff B, Kröger JC, Mahnken AH, Ittrich H, Gehl HB, Plessow B, Böttcher J, Tacke J, Wispler M, Rosien U, Schorr W, Joerdens M, Glaser N, Fuchs ES, Tal A, Friesenhahn-Ochs B, Leimbach T, Höpner L, Weber M, Gölder S, Böhmig M, Hetjens S, Rudi J, Schegerer A. Eur Radiol. 2019 Jul;29(7):3390-3400.
• Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study. Volckmar AL, Endris V, Gaida MM, Leichsenring J, Stögbauer F, Allgäuer M, von Winterfeld M, Penzel R, Kirchner M, Brandt R, Neumann O, Sültmann H, Schirmacher P, Rudi J, Schmitz D, Stenzinger A. Genes Chromosomes Cancer. 2019 Jan;58(1):3-11.
• Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care. Schimanski CC, Staib F, Göhler T, Hebart H, Heike M, Neise M, Rudi J, Geer T, Dingeldein G, Lang C, Ehscheidt P, Flohr T, Josten KM, Karthaus M, Schmittel A, Wierecky J, Boller E, Indorf M, Wörns MA, Galle PR, Moehler M. J Cancer Res Clin Oncol. 2017 Jun;143(6):1023-1034.
• Color Doppler ultrasound-guided PTBD with and without metal stent implantation by endoscopic control: prospective success and early adverse event rates. Schmitz D, Grosse A, Hallscheidt P, Roseneck A, Niemeyer J, Rudi J. Z Gastroenterol. 2015 Nov;53(11):1255-60.
• Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings. Kubicka S, Greil R, André T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, Müller T, Makrutzki M, Arnold D; ML18147 study investigators including AIO, GERCOR, FFCD, UNICANCER GI, TTD, BGDO, GEMCAD, and AGMT groups. Ann Oncol. 2013 Sep;24(9):2342-9.
• Helicobacter pylori-induced apoptosis in T cells is mediated by the mitochondrial pathway independent of death receptors. Ganten TM, Aravena E, Sykora J, Koschny R, Mohr J, Rudi J, Stremmel W, Walczak H. Eur J Clin Invest. 2007 Feb;37(2):117-25.
• Retrospective evaluation of combined modality treatment and prognostic factors in patients with esophageal cancer. Neuhof D, Neumayer F, Einbeck W, Haschemian K, Mai SK, Hochhaus A, Willeke F, Rudi J, Debus J, Wenz F. Acta Oncol. 2005;44(2):168-73.
• Infusional 5-fluorouracil and mitomycin C: an effective regimen in the treatment of advanced gastric cancer. Rudi J, Werle S, Bergtholdt D, Hofheinz RD. Onkologie. 2005 Mar;28(3):128-32.
• Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients. Staritz P, Kienle P, Koch M, Benner A, von Knebel Doeberitz M, Rudi J, Weitz J. J Exp Clin Cancer Res. 2004 Dec;23(4):633-9.
• Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy. Dimitrakopoulou-Strauss A, Strauss LG, Burger C, Rühl A, Irngartinger G, Stremmel W, Rudi J. J Nucl Med. 2004 Sep;45(9):1480-7.
• Role of apoptosis and CD95-receptor/ligand system in aspirin- and Helicobacter pylori-induced cell death. Domhan S, Stremmel W, Rudi J.Eur J Clin Invest. 2004 Jun;34(6):422-8.
• Association between cerebral ischemia and cytotoxin-associated gene-A-bearing strains of Helicobacter pylori. Preusch MR, Grau AJ, Buggle F, Lichy C, Bartel J, Black C, Rudi J. Stroke. 2004 Aug;35(8):1800-4.
• Salt and stomach cancer: chances for healthy nutrition. Stomach cancer--what is really reliable? Rudi J. Krankenpfl J. 2003;41(10-12):220-1.
• PET-FDG as predictor of therapy response in patients with colorectal carcinoma. Dimitrakopoulou-Strauss A, Strauss LG, Rudi J. Q J Nucl Med. 2003 Mar;47(1):8-13.
• Comparison of a 48-hour infusion of 5-fluorouracil without folinic acid with 24-hour folinic acid/5-fluorouracil in patients with metastatic colorectal cancer refractory to bolus folinic acid/5-fluorouracil. A prospective cohort study. Moehler M, Gutzler F, Steinmann S, Boehme M, Raeth U, Stremmel W, Galle PR, Rudi J. Chemotherapy. 2003 May;49(1-2):85-9. doi: 10.1159/000069778.
• Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin. Grau AJ, Buggle F, Lichy C, Brandt T, Becher H, Rudi J. J Neurol Sci. 2001 May 1;186(1-2):1-5.
• Chemotherapy with gemcitabine in patients with advanced gallbladder carcinoma. Teufel A, Lehnert T, Stremmel W, Rudi J. Z Gastroenterol. 2000 Nov;38(11):909-12.
• Helicobacter pylori vacA genotypes and cagA gene in a series of 383 H. pylori-positive patients. Rudi J, Kuck D, Rudy A, Sieg A, Maiwald M, Stremmel W. Z Gastroenterol. 2000 Jul;38(7):559-64.
• Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas. Wagner V, Rudi J, Näher H, Stremmel W. Med Oncol. 2000 Feb;17(1):35-8.
• Role of apoptosis in gastric epithelial turnover. von Herbay A, Rudi J. Microsc Res Tech. 2000 Mar 1;48(5):303-11.
• Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy. Hosch WP, Rudi J, Stremmel W. Z Gastroenterol. 1999 Jul;37(7):615-22.
• Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases. Rudi J, Rudy A, Maiwald M, Kuck D, Sieg A, Stremmel W. Am J Gastroenterol. 1999 Jun;94(6):1525-31.
• Helicobacter sp. are not detectable in bile from German patients with biliary disease. Rudi J, Rudy A, Maiwald M, Stremmel W. Gastroenterology. 1999 Apr;116(4):1016-7.
• Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. Rudi J, Kuck D, Strand S, von Herbay A, Mariani SM, Krammer PH, Galle PR, Stremmel W. J Clin Invest. 1998 Oct 15;102(8):1506-14.
• Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. Rudi J, Kolb C, Maiwald M, Kuck D, Sieg A, Galle PR, Stremmel W. J Clin Microbiol. 1998 Apr;36(4):944-8.
• Esophageal ulcer with heterotopy of the gastric mucosa and fistula. Rudi J, Stremmel W. Dtsch Med Wochenschr. 1998 Feb 27;123(9):269.
• Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients. Rudi J, Engler S, Theilmann L, Otto G, Stremmel W. Am J Gastroenterol. 1997 Sep;92(9):1492-5.
• Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Rudi J, Kolb C, Maiwald M, Zuna I, von Herbay A, Galle PR, Stremmel W. Dig Dis Sci. 1997 Aug;42(8):1652-9.
• Risk of infection with Helicobacter pylori and hepatitis A virus in different groups of hospital workers. Rudi J, Töppe H, Marx N, Zuna I, Theilmann L, Stremmel W, Raedsch R. Am J Gastroenterol. 1997 Feb;92(2):258-62.
• Lack of pharmacokinetic interaction of pantoprazole with diazepam in man. Gugler R, Hartmann M, Rudi J, Brod I, Huber R, Steinijans VW, Bliesath H, Wurst W, Klotz U. Br J Clin Pharmacol. 1996 Aug;42(2):249-52.
• Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy. Rudi J, Schönig T, Stremmel W. Z Gastroenterol. 1996 Mar;34(3):188-91.
• Serum hepatocyte growth factor levels in primary biliary cirrhosis. Rudi J, Waldherr R, Raedsch R, Stremmel W. Eur J Gastroenterol Hepatol. 1995 Nov;7(11):1081-6.
• Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Rudi J, Müller M, von Herbay A, Zuna I, Raedsch R, Stremmel W, Räth U. Scand J Gastroenterol. 1995 Oct;30(10):958-63.
• Development of malignancies and chronic inflammations of the gastrointestinal tract--new concepts. Rudi J. Leber Magen Darm. 1995 Jul;25(4):184-5.
• Effect of ursodeoxycholic acid on biochemical parameters, hepatocyte proliferation and liver histology in galactosamine hepatitis in the rat. Rudi J, Schlenker T, Raedsch R, Waldherr R, Zorn M, Stremmel W. Res Exp Med (Berl). 1995;195(5):309-15.
• Simultaneous gastric adenocarcinoma and MALT-type lymphoma in Helicobacter pylori infection. von Herbay A, Schreiter H, Rudi J. Virchows Arch. 1995;427(4):445-50.
• Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling. Rudi J, Waldherr R, Raedsch R, Kommerell B. J Hepatol. 1995 Jan;22(1):43-9.
• Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment. Rudi J, Raedsch R, Gerteis C, Schlenker T, Plachky J, Walter-Sack I, Sabouraud A, Scherrmann JM, Kommerell B. Scand J Gastroenterol. 1994 Apr;29(4):346-51.
• Visceral leishmaniasis (kala-azar) after a visit to the Mediterranean region. Rudi J, Racz P, Hörner M, Kommerell B. Clin Investig. 1993 Aug;71(8):616-9.
• Lack of accumulation of midazolam in plasma and lipoprotein fractions during intravenous lipid infusions in patients on artificial respiration. Walter-Sack I, de Vries JX, Rudi J, Conradi R, Kohlmeier M, Kohl B, Weber E. Eur J Clin Pharmacol. 1992;42(1):71-5.
• The determination of total and unbound midazolam in human plasma. A comparison of high performance liquid chromatography, gas chromatography and gas chromatography/mass spectrometry. de Vries JX, Rudi J, Walter-Sack I, Conradi R. Biomed Chromatogr. 1990 Jan;4(1):28-33.
• Increased prevalance of colorectal adenoma in patients with sporadic duodenal adenoma. Dariusz A, Jochen R. Eur J Gastroenterol Hepatol. 2009 Jul;21(7):816-8.

• Liste der Veröffentlichungen von Prof. Dr. Dieter Schilling 

Erstautorenschaften/Letztautorenschaften: Originalartikel

• Keese M A, Boese M, Mülsch A, Schirmer R H, Becker K (1997) Imp. - 3,581 Dinirosyl-Dithiol-Iron Complexes, Nitric Oxide (NO) Carriers in vivo, as potent inhibitors of human glutathione reductase and glutathione-S-transferase. Biochem. Pharmacol. 54, 1307-1313
• Keese M A, Saffrich R, Dandekar T, Schirmer R H & Becker K (1999) Imp. - 3,372 Microinjected glutathione reductase crystals as indicators of the redox status in living cells. FEBS Lett 447, 135-138 (both first authors contributed equally)
• Keese M, Magdeburg R J, Herzog T, Hasenberg T, Offterdinger M, Pepperkok R, Sturm J W, Bastiaens P I (2005) IMP. - 5,808 Imaging epidermal growth factor receptor phosphorylation in human colorectal cancer cells and human tissues. J. Biol. Chem. 280: 27826-31.
• Keese M, Offterdinger M, Tischer C, Girod A, Yagublu V, Magdeburg, R and Bastiaens P I (2007) Imp. - 3,745 Quantitative imaging of apoptosis commitment in colorectal tumor cell Differentiation 75: 809-18 (both first authors contributed equally)
• Keese M, Gasimova L, Schwenke K, Yagublu V, Shang E, Faissner R, Lewis A, Samel S and Löhr M (2009) Imp- 4,555 Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer Int J Cancer 124: 2701-2708
• Keese M, Yagublu V., Offterdinger M, Neufang T, Post S., and Bastiaens P I (2008) Imp 4,926 Fluorescence lifetime imaging of apotosis commitment under chemotherapy by in a syngenic mouse tumor model Int J. Cancer 126: 104-13. (both first authors contributed equally)
• Guo-yang W, Hasenberg T, Magdeburg R, Bönninghoff R, Sturm JW, Keese M (2009) Imp.- 1,778 Association between EGF, TGF-β1, VEGF gene polymorphism and colorectal cancer World J Surg 33:124-9
• Hasenberg T, Keese M, Längle F, Reibenwein B, Schindler K, Herold A, Beck G, Post S, Jauch K W, Spies C., Schwenk W,, Shang E. (2009) Imp.- 2,059 "Fast-track"-colonic surgery in Austria and Germany - results from the survey on patterns in current peri-operative practice. Colorectal Dis. 11:162-7. (both first authors contributed equally)
• Wu G ., Lu Q, Hasenberg T, Niedergethmann M, Post S, Sturm J W., Keese M (2011) Imp 1,646 Association between EGF, TGF-{beta}1, TNF-{alpha} gene polymorphisms and cancer of the pancreatic head. Anticancer Res. 30: 5257-61.
• Yagublu V, Arthur JR, Babayeva SN, Nicol F, Post S, Keese M (2011) Imp 1,646 Expression of selenium-containing proteins in human colon carcinoma tissue Anticancer Res 31: 2693-8.
• Magdeburg R, Kessler M, Keese M (2012) Imp 1,143 Imaging EGFR Phosphorylation in Intact Pancreatic Carcinoma Cells In Vivo 26: 619-25
• Zhang L, Wu G, Herrle F, Niedergethmann M, Keese M (2012) Imp 2,800 Single Nucleotide Polymorphisms of Genes for EGF, TGF-β and TNF-α in Patients with Pancreatic Carcinoma CANCER GENOMICS & PROTEOMICS; 9: 287-95
• Binder S, Lewis A, Jesenofsky R, Neumaier M, Jäger E, Ströbel P, Keese M (2012) Imp 1,646 Intraperitoneal Use of Doxorubicin-eluting Beads in Sheep: A Pilot Safety Study Anticancer Res 32: 5167-74.
• Yagublu V, Caliskan N, Lewis AL, Jesenofsky R, Gasimova L, Löhr J.-M, Keese M (2013) Imp 2,399 Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinitocan-drug eluting beads Pancreatology 13: 79-87
• Yagublu V, Ahmadova A, Hajiyeva Y, Hafner M, Keese M (2013) Imp 1,646 Combination of the EGFR Tyrosine Kinase Inhibitor AG1478 and 5-FU: No Synergistic Effect on EGFR Phosphorylation, Cell Proliferation and Apoptosis Induction Anticancer Res, 33:3753-8.
• Ahmadova Z, Yagublu V, Förg T, Hajiyeva Y, Jesofsky R, Hafner M, Keese M (2014) Imp 1,646 Fluorescent Resonance Energy Transfer Imaging of VEGFR Dimerization Anticancer Res. 34:2123-33.
• Gkremoutis A, Schmandra T, Meyn M, Schmitz-Rixen T, Keese M (2014) Imp 2,93 Hybrid Approach to Emergent and Urgent Treatment of Complex Thoracoabdominal Aortic Pathology Eur J Vasc Endovac Surg 48: 407-13
• Erfle H, Pashayeva K, Harder N, Zhang L, Rohr K, Schadendorf D, Ugurel S, Keese M. (2015) Imp 3,70 Targeting mitosis-regulating genes in cisplatin-sensitive and –resistant melanoma cells: A live-cell RNAi screen displays differential nucleus-derived phenotypes Biotechnol J 10:1467-77
• Zhang L, Erfle H, Harder N, Beneke J, Beil N, Bulkescher R, Rohr K, Keese M. (2016) Imp 3,189 High-throughput RNAi screening identifies a role for the Osteopontin pathway in proliferation and migration of human aortic smooth muscle cells Cardiovasc Drugs Ther. 30:281-95.
• Kazemtash M, Harth M, Derwich W, Thalhammer A, Schmitz-Rixen T, Keese M. Quiescent-Interval Slice Selective Magnetic Resonance Angiography for Abdominal Aortic Aneurysm Treatment Planning. J Endovasc Ther. 2021 Jan 22:1526602821989341. doi: 10.1177/1526602821989341. Online ahead of print.PMID: 33478349
• Kan K, Mu Y, Bouschbacher M, Sticht C, Kuch N, Sigl M, Rahbari N, Gretz N, Pallavi P, Keese. Biphasic Effects of Blue Light Irradiation on Human Umbilical Vein Endothelial Cells. Biomedicines. 2021 Jul 16;9(7):829.
• Kan KJ, Guo F, Zhu L, Pallavi P, Sigl M, Keese M. Weighted Gene Co-Expression Network Analysis Reveals Key Genes and Potential Drugs in Abdominal Aortic Aneurysm. Biomedicines. 2021 May 13;9(5):546.
• Yan K, Zheng J, Zöllner FG, Schwenke K, Pallavi P, Keese M. A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision. J Vis Exp. 2021 May 13;(171)
• Wang Z, Zeng Z, Starkuviene V, Erfle H, Kan K, Zhang J, Gunkel M, Sticht C, Rahbari N, Keese M. MicroRNAs Influence the Migratory Ability of Human Umbilical Vein Endothelial Cells. Genes (Basel). 2022 Apr 2;13(4):640
• Zhang J, Starkuviene V, Erfle H, Wang Z, Gunkel M, Zeng Z, Sticht C, Kan K, Rahbari N, Keese M.
• High-content analysis of microRNAs involved in the phenotype regulation of vascular smooth muscle cells. Sci Rep. 2022 Mar 3;12(1):3498.
• Li L, Kan K, Pallavi P, Keese M. Identification of the Key Genes and Potential Therapeutic Compounds for Abdominal Aortic Aneurysm Based on a Weighted Correlation Network Analysis. Biomedicines. 2022 May 2;10(5):1052
• Yan K, Zheng J, Kluth MA, Li L, Ganss C, Yard B, Magdeburg R, Frank MH, Pallavi P, Keese M. ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo. Stem Cell Res Ther. 2023 Feb 9;14(1):24
• Li L, Zeng Z, Yagublu V, Rahbari N, Reißfelder C, Keese M. Analysis of Inflammation-Related Genes in Patients with Stanford Type A Aortic Dissection. J Pers Med. 2023 Jun 13;13(6):990
• Guo F, Kan K, Rückert F, Rückert W, Li L, Eberhard J, May T, Sticht C, Dirks WG, Reißfelder C, Pallavi P, Keese M Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines. Int J Mol Sci. 2023 Aug 31;24(17):13530

Buchbeitäge/Reviews/Case Reports:

• Becker K, Keese M A, Gromer S, Schirmer R H (1996) Flavins in medicine. An update. Falvins and Falvoproteins Vol. 12 (Stevenson K. J., Massey V., Williams C. H. Jr., eds) University Press Calgary
• Sturm J W, Keese M A, Bonninghoff R, Wustner M, Post S (2001) - Imp. 1,724 Locally ablative therapies of hepatocellular carcinoma Onkologie; 24 Suppl 5: 35-45
• Keese M, Nichterlein T, Hahn M, Magdeburg R, Karaormann M, Back W, Sturm J W, Kerger H (2003) - Imp. 2,314 Gas Gangrene pyemia with myocardial abscess formation - Fatal Outcome of a nowadays rare infection Resuscitation. 58: 219-25
• Sturm J W, Keese M (2004) - Imp. 1,724 Multimodal treatment of hepatocellular carcinoma (HCC). Onkologie. 27: 294-303. Review.
• Keese M, Back W, Dienter D, Gladisch R, Joos A, Palma P (2005) Late perineal mucinous adenocarcinoma after crohns disease proctectomy: an oncolocigal rarity. World J. Surg. Oncol.; 3:42.
• Keese M, Riester T, Schwenke K, Dinter D, Back W and Palma P (2007)- Imp. 0,909 Acute GI bleeding by multiple jejunal gastrointestinal autonomic nerve tumour associated with neurofibromatosis type 1 Rev Esp Enferm Dig 99, 608-611
• Keese M, Niedergethmann M, Schoenberg S, Diehl S. (2011) Placement of an aortomonoiliac stent graft without femorofemoral revascularization in endovascular aneurysm repair: a case report. J Med Case Rep. 2011 Aug 12;5:365.
• Keese M, Diehl SJ, Huck K, Ströbel P, Schoenberg SO, Niedergethmann M (2012) Imp 1,436 Cystic Adventitial degeneration of the popliteal artery Ann Vasc Surg. 26: 859.e17-21
• Keese M, Bihari P, Meyn M, Schmandra T, Schmitz-Rixen T (2011) Periphere Bypasschirurgie der unteren Extremität Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, Vol. 25266-275
• Mayer K, Keese M, Schmandra Th, Meyn M, Schmitz-Rixen T (2012) Operative Behandlung der tiefen Venenthrombose MWW Fortschritte Medizin 154 : 79-85
• Yagublu V, Ahmadova Z, Hafner M, Keese M (2012) Imp 1,143 Fluorescent Protein-based Tumor Models In Vivo, 26:599-607
• Keese M, Schmitz-Rixen T, Schmandra T (2013) Imp 2,471 Chronic mesenteric ischemia: a plea for open revascularization World J. Gastroenterol. 19:1333-7
• Binder S, Lewis AL, Löhr JM, Keese M (2013) Imp 2,471 Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapy World J Gastroenterol 19: 7586-93
• Schmitz-Rixen Th, Keese M (2014) Team Time Out – bevor es zu spät ist in ”Risikomanagement und Fehlervermeidung im Krankenhaus” Springer Verlag/LÄKH 121-128
• KeeseM, Henrich D (2014) Mastering Surgical Biology – eine Retrospektive der 17. Chirurgischen Forschungstage in Frankfurt Zentralblatt für Chirurgie 139:e19-20.
• Schmitz-Rixen T, Keese M, Hakimi M, Peters A, Böckler D, Nelson K, Grundmann RT (2016) Ruptured abdominal aortic aneurysm-epidemiology, predisposing factors, and biology. Langenbecks Arch Surg. 401, 275-88
• Peters AS, Hakimi M, Erhart P, Keese M, Schmitz-Rixen T, Wortmann M, Bischoff MS, Böckler D. (2016=) Current treatment strategies for ruptured abdominal aortic aneurysm. Langenbecks Arch Surg 401:289-98.
• Keese M, Dahi F, Lindhoff-Last E.A (2017) Imp 1,436 Synovial Cyst Originating from the Hip Joint as a Rare Cause of Recurrent Femoral Vein Thrombosis: Case Report and Literature Review .Ann Vasc Surg. 299.e11-299.e14
• Dahi F, Gkremoutis A, Harth M, Schmitz-Rixen T, Keese M (2017) Imp 1,436Thrombosis of the Inferior Vena Cava after Endovascular Aortic Repair in a Patient with May-Thurner Syndrome: Case Report and Literature Review. Ann Vasc Surg40:299.e11-299.e14.
• Dahi F, Keese M, Thalhammer A, Schmitz-Rixen T, Gkremoutis A.Dahi F (2019) An Enigmatic Case of an Uncommon Syndrome: The Hughes-Stovin Syndrome. Ann Vasc Surg. 2019 Oct;60:474.e7-474.e10

Koautorenschaften (Originalartikel)

• Boese M, Keese M A., Becker K, Busse R, Mülsch A (1997) - Imp. 5,808 Inhibition of glutathione reductase by dinitrosyl-iron-dithiolate complex. J. Biol. Chem. 272, 21767-21773
• Becker K, Savvides S N, Keese M A, Schirmer R H & Karplus P A (1998) - Imp. 11,502 Inactivation of glutathione reductase by S-Nitrosoglutathione and Dinitroso-dithiol-iron-complexes. Nature Structural Biology 5, 267-271
• Sturm J, Magdeburg J R, Berger K, Petruch B, Samel S, Bönninghoff R, Keese M, Hafner M, Post S (2003) Imp - 4,926
• Influence of TNFa on the formation of liver metastases in a syngenic mouse model Int J Cancer 107: 11-21.
• Samel S., Keese M, Kleczka M, Lanig S. Gretz N, Hafner M, Sturm J, Post S (2003) Imp - 3,318 Supplementation and inhibition of NO-synthesis influences bacterial transit time during bacterial translocation in rats Shock. 19: 378-82
• Sturm J W, Keese M A, Petruch B, Bonninghoff R, Zhang H, Gretz N, Hafner M, Post S, Mc Cuckey R (2003) Imp. - 1,986 Enhanced Green Fluorescent Protein-transfection of murine colon carcinoma cells: key for early tumor detection and quantification Clin Exp Metastasis. 20: 395-405
• Samel S, Keese M, Lux A, Jesnowski R, Prosst R, Saller A, Hafner M, Sturm J Post S., Löhr M (2005) - Imp. 4,187 Peritoneal cancer treatment with CYP2B1 transfected, microen-capsulated cells and ifosfamide. Cancer Gene Ther. 13:65-73.
• Becker K, Müller S, Keese M A, Walter R D, Schirmer R H (1996) – Imp. 2,962 A glutathione reductase-like flavoenzyme of the malaria parasite Plasmodium falciparum: structural considerations based on the DNA sequence. Biochem. Soc. Trans. 24, 67-72
• Samel S, Lanig S, Lux A, Keese M, Gretz N, Nichterlein T, Sturm J, Lohr M, Post S (2002) - Imp 2,147 The gut origin of bacterial pancreatic infection during acute experimental pancreatitis in rats. Pancreatology 2: 449-55.
• Samel S, Keese M, Kleczka M, Lanig S, Gretz N, Hafner M, Sturm J, Post S (2002) – Imp 1,97 Microscopy of bacterial translocation during small bowel obstruction and ischemia in vivo - a new animal model. BMC Surg. 13: 6.
• Sturm J, Keese M, Zhang H, Bonninghoff R, Magdeburg R, Vajkoczy R, Post S, Dono R, Zeller R, Gretz N (2004) - Imp 2,344 Liver regeneration in FGF-2-deficient mice: VEGF acts as potential functional substitute for FGF-2. Liver Int. 24:161-8.
• Gerhardt A, Usener D, Keese M, Sturm J, Schadendorf D, Eichmuller S (2004) - Imp 3,277 Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer. Cancer Lett. 208:197-206.
• Sturm J W, Zhang H, Magdeburg R, Hasenberg T, Bonninghoff R, Oulmi J, Keese M, McCuskey R (2004) - Imp. 3,558 Altered apoptotic response and different liver structure during liver regeneration in FGF-2-deficient mice. Cell Physiol Biochem. 14: 249-60
• Kondepati V R, Zimmermann J, Keese M, Sturm J, Manegold B C, and Backhaus J (2005) - Imp. 2,870 Near-infrared fiber optic spectroscopy as a novel diagnostic tool for the detection of pancreatic cancer J. Biomed. Opt. 10:54016
• Kondepati V R, Keese M, Heise M, Backhaus J (2006) - Imp. 1,880 Detection of structural disorders in pancreatic tumour DNA with Fourier-transform infrared spectroscopy Vibrational Spectroscopy, 40: 33-39
• Wu G Y, Wang X M, Keese M, Hasenberg T, Sturm J W Association between vascular endothelial growth factor gene 936 T/C polymorphism and colorectal cancer together with anastomotic leakage (2006) Zhonghua Wai Ke Za Zhi 44:1505-7.
• Kondepati V R, Keese M, Mueller R, Backhaus J (2007) - Imp. 1,880 Near-infrared spectroscopic detection of human colon diverticulitis: A pilot study Vibrational Spectroscopy 44: 56-61
• Kondepati VR, Oszinda T, Heise H M, Luig K, Mueller R, Schroeder O, Keese M, Backhaus J (2007) - Imp. 2,591 CH-overtone regions as diagnostic markers for near-infrared spectroscopic diagnosis of primary cancers in human pancreas and colorectal tissue. Anal Bioanal Chem. 387: 1633-1641
• Palma P, Mihaljevic N, Hasenberg T, Keese M and Koeppel T A (2007) - Imp 1,255 Intestinal barrier dysfunction in developing liver cirrhosis: An in vivo analysis of bacterial translocation Hepatology Research 37: 6-12
• Moss D, Keese M, Pepperkok R (2005) - Imp. 1,880 IR microspectroscopy of live cells Vibrational Spectroscopy 38: 185-91
• Kondepati V R, Keese M, Mueller R, Manegold B C, Backhaus J (2007) - Imp. 1,880 Application of near infrared spectroscopy for the diagnosis of resected human tissue specimens Vibrational Spectroscopy 44: 236-242
• Kondepati V R, Heise H M, Oszinda T, Mueller R, Keese M, Backhaus J (2007) - Imp. 1,780 Detection of structural disorders in colorectal cancer DNA with Fourier-transform infrared spectroscopy Vibrational Spectroscopy 46: 50-157
• Bönninghoff R, Schwenke K, Otto M, Post S, Bitter-Suermann H, Keese M, Sturm J (2012) Imp 1,054 Effect on different liver resection methods in a syngenic murine tumor model Can J Surg. 55: 007911-411
• Rathmann N, Hausmann D, Kostrzewa M, Keese M, Diehl S, Schönberg S, Sadick M (2011) Imp 0,523 Complications of venous port systems : Radiological diagnostics and minimally invasive therapy. Radiologe 51:397-402
• Diehl SJ, Gerblich F, Jochum S, Huck K, Keese M, Schoenberg SO, Sadick M. (2012) 2.075 Twelve-Month Results of the EverFlex Stent in the Superficial Femoral Artery. J Vasc Interv Radiol. 23:1317-22.
• Meyer Dos Santos S, Blankenbach K, Scholich K, Dörr A, Monsefi N, Keese M, Linke B, Deckmyn H, Nelson K, Harder S (2015) Imp 5,255 Platelets from flowing blood attach to the inflammatory chemokine CXCL16 expressed in the endothelium of the human vessel wall Thromb Haemost 114:297-312
• Linke B, Meyer Dos Santos S, Picard-Willems B, Keese M, Harder S, Geisslinger G, Scholich K. (2017) Imp 2,6 CXCL16/CXCR6-mediated adhesion of human peripheral blood mononuclear cells to inflamed endothelium. Cytokine. S1043-4666
• Gkremoutis A, Zierer A, Schmitz-Rixen T, El-Sayed Ahmad A, Kaiser E, Keese M, Schmandra T. (2017) Imp 4,168 Staged treatment of mega aortic syndrome using the frozen elephant trunk and hybrid thoracoabdominal repair. J Thorac Cardiovasc Surg. 2017 Dec;154(6):1842-1849
• Karampinis I, Keese M, Jakob J, Stasiunaitis V, Gerken A, Attenberger U, Post S, Kienle P, Nowak K. Imp 2,962 Indocyanine Green Tissue Angiography Can Reduce Extended Bowel Resections in Acute Mesenteric Ischemia. J Gastrointest Surg. 2018 Jul 10
• Karampinis I, Keese M, Jakob J, Stasiunaitis V, Gerken A, Attenberger U, Post S, Kienle P, Nowak .Karampinis I (2018) Indocyanine Green Tissue Angiography Can Reduce Extended Bowel Resections in Acute Mesenteric Ischemia. J Gastrointest Surg. 2018 Dec;22(12):2117-2124
• Seiler A, Kammerer S, Gühl A, Schüre JR, Deichmann R, Nöth U, Pfeilschifter W, Hattingen E, Keese M, Pilatus U, Wagner M. (2019) Revascularization of High-Grade Carotid Stenosis Restores Global Cerebral Energy Metabolism. Stroke. 2019 Jul;50(7):1742-1750.
• Hohneck A, Keese M, Ruemenapf G, Amendt K, Muertz H, Janda K, Akin I, Borggrefe M, Sigl M.Hohneck A (2019) Prevalence of abdominal aortic aneurysm and associated lower extremity artery aneurysm in men hospitalized for suspected or known cardiopulmonary disease. Keese M. BMC Cardiovasc Disord. 2019 Dec 9;19(1):
• Rother U, Amann K, Adler W, Nawroth N, Karampinis I, Keese M, Manap S, Regus S, Meyer A, Porubsky S, Hilgers K, Krämer BK, Lang W, Nowak K, Gerken ALH (2019) Quantitative assessment of microperfusion by indocyanine green angiography in kidney transplantation resembles chronic morphological changes in kidney specimens. Microcirculation. 2019 Apr;26(3):e12529.
• Prospective Evaluation of the Pre-, Intra-, and Postoperative Kinetics of ADAMTS-13, von Willebrand Factor, and Interleukin-6 in Vascular Surgery.
• Häußler KS, Keese M, Weber CF, Geisen C, Miesbach W.Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620930273
• Shchetynska-Marinova T, Amendt K, Sadick M, Keese M, Sigl M. Aortitis - An Interdisciplinary Challenge. In Vivo. 2021 Jan-Feb;35(1):41-52. doi: 10.21873/invivo.12230.PMID: 33402448 Review.
• Gerken ALH, Nowak K, Meyer A, Weiss C, Krüger B, Nawroth N, Karampinis I, Heller K, Apel H, Reissfelder C, Schwenke K, Keese M, Lang W, Rother U. Quantitative Assessment of Intraoperative Laser Fluorescence Angiography with Indocyanine Green Predicts Early Graft Function after Kidney Transplantation. Ann Surg. 2022 Aug 1;276(2):391-397.
• Halliday A, Bulbulia R, Bonati LH, Chester J, Cradduck-Bamford A, Peto R, Pan H; ACST-2 Collaborative Group Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy..Lancet. 2021 Sep 18;398(10305):1065-1073. doi: 10.1016/S0140-6736(21)01910-3. Epub 2021 Aug 2
• Téoule P, Tombers K, Rahbari M, Sandra-Petrescu F, Keese M, Rahbari NN, Reißfelder C, Rückert F.[Definition and treatment of superior mesenteric artery revascularization and dissection-associated diarrhea (SMARD syndrome) in Germany]. Chirurg. 2022 Feb;93(2):173-181. doi: 10.1007/s00104-021-01427-4.
• Jabbour E, Fütterer C, Zach S, Kälsch AI, Keese M, Rahbari NN, Krämer BK, Schwenke KG.Implantation of a peritoneal dialysis catheter in patients with ESRD using local anesthesia and Remifentanil.PLoS One. 2021 Nov 4;16(11):e0259351.
• Kazimi AU, Weber CF, Keese M, Miesbach W. The Pre- and Postoperative Prevalence and Risk Factors of ASA Nonresponse in Vascular Surgery. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211044723.
• Golla AK, Tönnes C, Russ T, Bauer DF, Froelich MF, Diehl SJ, Schoenberg SO, Keese M, Schad LR, Zöllner FG, Rink JS. Automated Screening for Abdominal Aortic Aneurysm in CT Scans under Clinical Conditions Using Deep Learning. Diagnostics (Basel). 2021 Nov 17;11(11):2131
• Yazdani B, Marinez J, Krüger B, Kälsch AI, Jung M, Chen G, Leipe J, Benck U, Schnülle P, Nuhn P, Keese M, Schwenke K, Krämer BK. Patient and Graft Survival After Dual Kidney Transplantation With Marginal Donors in Comparison to Matched Control Groups. Transplant Proc. 2021 Sep;53(7):2180-2187.
• Gerken ALH, Nowak K, Meyer A, Weiss C, Krüger B, Nawroth N, Karampinis I, Heller K, Apel H, Reissfelder C, Schwenke K, Keese M, Lang W, Rother U. Quantitative Assessment of Intraoperative Laser Fluorescence Angiography With Indocyanine Green Predicts Early Graft Function After Kidney Transplantation. Ann Surg. 2022 Aug 1;276(2):391-397.
• Gerken ALH, Keese M, Weiss C, Krücken HS, Pecher KAP, Ministro A, Rahbari NN, Reissfelder C, Rother U, Yazdani B, Kälsch AI, Krämer BK, Schwenke K. Investigation of Different Methods of Intraoperative Graft Perfusion Assessment during Kidney Transplantation for the Prediction of Delayed Graft Function: A Prospective Pilot Trial. J Pers Med. 2022 Oct 21;12(10):1749
• Nardozi D, Palumbo S, Khan AUM, Sticht C, Bieback K, Sadeghi S, Kluth MA, Keese M, Gretz N Potential Therapeutic Effects of Long-Term Stem Cell Administration: Impact on the Gene Profile and Kidney Function of PKD/Mhm (Cy/+) Rats. .J Clin Med. 2022 May 5;11(9):2601
• An L, Michaeli J, Pallavi P, Breedijk A, Xu X, Dietrich N, Sigl M, Keese M, Nitschke K, Jarczyk J, Nuhn P, Krämer BK, Yard BA, Leipe J. Concurrent stimulation of monocytes with CSF1 and polarizing cytokines reveals phenotypic and functional differences with classical polarized macrophages. J Leukoc Biol. 2022 Sep;112(3):437-447
• Sigl M, Baumann S, Könemann AS, Keese M., Schwenke K, Gerken ALH, Dürschmied D, Rosenkaimer S.
• Prognostic value of extended cardiac risk assessment before elective open abdominal aortic surgery. Herz. 2023 Oct 3.

Auszug aus dem Publikationsverzeichnis von Prof. Dr. Markus Haass:

• Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial. Packer M, Anker SD, Butler J, Filippatos G, Ferreira JP, Pocock SJ, Carson P, Anand I, Doehner W, Haass M, Komajda M, Miller A, Pehrson S, Teerlink JR, Brueckmann M, Jamal W, Zeller C, Schnaidt S, Zannad F. Circulation. 2021 Jan 26;143(4):326-336. Epub 2020 Oct 21.
• Diagnosis of heart failure with preserved ejection fraction. Not seeing the forest for the trees or a step to precision medicine? Korosoglou G, Haass M.Int J Cardiovasc Imaging. 2021 Aug;37(8):2497-2499.
• A multi-vendor, multi-center study on reproducibility and comparability of fast strain-encoded cardiovascular magnetic resonance imaging. Erley J, Zieschang V, Lapinskas T, Demir A, Wiesemann S, Haass M, Osman NF, Simonetti OP, Liu Y, Patel AR, Mor-Avi V, Unal O, Johnson KM, Pieske B, Hansmann J, Schulz-Menger J, Kelle S. Int J Cardiovasc Imaging. 2020 May;36(5):899-911. doi: 10.1007/s10554-020-01775-y. Epub 2020 Feb 13.
• Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial. Packer M, Butler J, Zannad F, Filippatos G, Ferreira JP, Pocock SJ, Carson P, Anand I, Doehner W, Haass M, Komajda M, Miller A, Pehrson S, Teerlink JR, Schnaidt S, Zeller C, Schnee JM, Anker SD.Circulation. 2021 Oct 19;144(16):1284-1294. Epub 2021 Aug 29.
• Symptom Severity and Health-Related Quality of Life in Patients with Atrial Fibrillation: Findings from the Observational ARENA Study. Sadlonova M, Senges J, Nagel J, Celano C, Klasen-Max C, Borggrefe M, Akin I, Thomas D, Schwarzbach CJ, Kleeman T, Schneider S, Hochadel M, Süselbeck T, Schwacke H, Alonso A, Haass M, Ladwig KH, Herrmann-Lingen C. J Clin Med. 2022 Feb 21;11(4):1140.
• Case report: Case series of isolated acute pericarditis after SARS-CoV-2 vaccinations. Ochs MM, Haass M, Hagstotz S, Giusca S, Korosoglou G. Front Cardiovasc Med. 2022 Aug 17;9:990108.
• Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial. Carson P, Teerlink JR, Komajda M, Anand I, Anker SD, Butler J, Doehner W, Ferreira JP, Filippatos G, Haass M, Miller A, Pehrson S, Pocock SJ, Schnaidt S, Schnee JM, Zannad F, Packer M. JACC Heart Fail. 2023 Apr;11(4):407-417. Epub 2023 Feb 1.
• Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie BM, Carson PE; I-Preserve Investigators. Circulation. 2010 Mar 30;121(12):1393-405. doi: 10.1161/CIRCULATIONAHA.109.909614. Epub 2010 Mar 15.
• Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE. Circ Heart Fail. 2011 May;4(3):324-31. doi: 10.1161/CIRCHEARTFAILURE.110.959890. Epub 2011 Feb 24.
• Individual differences in multitasking ability and adaptability. Morgan B, D'Mello S, Abbott R, Radvansky G, Haass M, Tamplin A. Hum Factors. 2013 Aug;55(4):776-88.
• Position paper on the importance of psychosocial factors in cardiology: Update 2013. Ladwig KH, Lederbogen F, Albus C, Angermann C, Borggrefe M, Fischer D, Fritzsche K, Haass M, Jordan J, Jünger J, Kindermann I, Köllner V, Kuhn B, Scherer M, Seyfarth M, Völler H, Waller C, Herrmann-Lingen C. Ger Med Sci. 2014 May 7;12:Doc09. doi: 10.3205/000194. eCollection 2014.
• Aldosterone augments Na+-induced reduction of cardiac norepinephrine reuptake. Kreusser MM, Lehmann LH, Riffel JH, Haass M, Maser-Gluth C, Backs J, Katus HA, Buss SJ. Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1169-77. doi: 10.1152/ajpheart.00193.2014. Epub 2014 Aug 15.
• Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling. Lehmann LH, Rostosky JS, Buss SJ, Kreusser MM, Krebs J, Mier W, Enseleit F, Spiger K, Hardt SE, Wieland T, Haass M, Lüscher TF, Schneider MD, Parlato R, Gröne HJ, Haberkorn U, Yanagisawa M, Katus HA, Backs J. Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13499-504. doi: 10.1073/pnas.1409026111. Epub 2014 Sep 2.
• Potentially modifiable correlates of functional status in patients with chronic heart failure. Lossnitzer N, Wild B, Schultz JH, Frankenstein L, Haass M, Rauch B, Löwe B, Katus H, Herzog W. Int J Behav Med. 2014 Dec;21(6):956-60.
• The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). Carson PE, Anand IS, Win S, Rector T, Haass M, Lopez-Sendon J, Miller A, Teerlink JR, White M, McKelvie RS, Komajda M, Zile MR, McMurray JJ, Massie B. JACC Heart Fail. 2015 Jun;3(6):429-441. Epub 2015 May 14.
• Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial. Angermann CE, Gelbrich G, Störk S, Gunold H, Edelmann F, Wachter R, Schunkert H, Graf T, Kindermann I, Haass M, Blankenberg S, Pankuweit S, Prettin C, Gottwik M, Böhm M, Faller H, Deckert J, Ertl G; MOOD-HF Study Investigators and Committee Members. JAMA. 2016 Jun 28;315(24):2683-93.
• Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter. Kreusser MM, Lehmann LH, Haass M, Buss SJ, Katus HA, Lossnitzer D. PLoS One. 2017 Mar 10;12(3):e0172070. eCollection 2017.
• ARENA-Project atrial fibrillation in the Rhein-Neckar region. Baumann S, Grau A, Senges J, Schneider S, Alonso A, Katus HA, Thomas D, Waldecker B, Haass M, Zahn R, Zeymer U, Akin I, Kruska M, Fischer C, Borggrefe M. Herz. 2020 Nov;45(7):689-695. Epub 2019 Jan 9.
• Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study. Bavendiek U, Berliner D, Dávila LA, Schwab J, Maier L, Philipp SA, Rieth A, Westenfeld R, Piorkowski C, Weber K, Hänselmann A, Oldhafer M, Schallhorn S, von der Leyen H, Schröder C, Veltmann C, Störk S, Böhm M, Koch A, Bauersachs J; DIGIT-HF Investigators and Committees (see Appendix). Eur J Heart Fail. 2019 May;21(5):676-684. doi: 10.1002/ejhf.1452. Epub 2019 Mar 20.
• Significance of psychosocial factors in cardiology: update 2018 : Position paper of the German Cardiac Society. Albus C, Waller C, Fritzsche K, Gunold H, Haass M, Hamann B, Kindermann I, Köllner V, Leithäuser B, Marx N, Meesmann M, Michal M, Ronel J, Scherer M, Schrader V, Schwaab B, Weber CS, Herrmann-Lingen C. Clin Res Cardiol. 2019 Nov;108(11):1175-1196. Epub 2019 May 10.
• Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Schulz M, Griese-Mammen N, Anker SD, Koehler F, Ihle P, Ruckes C, Schumacher PM, Trenk D, Böhm M, Laufs U; PHARM-CHF Investigators. Eur J Heart Fail. 2019 Aug;21(8):1012-1021. Epub 2019 Jun 7.
• A multi-vendor, multi-center study on reproducibility and comparability of fast strain-encoded cardiovascular magnetic resonance imaging. Erley J, Zieschang V, Lapinskas T, Demir A, Wiesemann S, Haass M, Osman NF, Simonetti OP, Liu Y, Patel AR, Mor-Avi V, Unal O, Johnson KM, Pieske B, Hansmann J, Schulz-Menger J, Kelle S. Int J Cardiovasc Imaging. 2020 May;36(5):899-911. Epub 2020 Feb 13.
• Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial. Packer M, Anker SD, Butler J, Filippatos G, Ferreira JP, Pocock SJ, Carson P, Anand I, Doehner W, Haass M, Komajda M, Miller A, Pehrson S, Teerlink JR, Brueckmann M, Jamal W, Zeller C, Schnaidt S, Zannad F. Circulation. 2021 Jan 26;143(4):326-336. Epub 2020 Oct 21.
• Diagnosis of heart failure with preserved ejection fraction. Not seeing the forest for the trees or a step to precision medicine? Korosoglou G, Haass M. Int J Cardiovasc Imaging. 2021 Aug;37(8):2497-2499.
• Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial. Packer M, Butler J, Zannad F, Filippatos G, Ferreira JP, Pocock SJ, Carson P, Anand I, Doehner W, Haass M, Komajda M, Miller A, Pehrson S, Teerlink JR, Schnaidt S, Zeller C, Schnee JM, Anker SD. Circulation. 2021 Oct 19;144(16):1284-1294. Epub 2021 Aug 29.

1. Hambsch N, Warken M, Soehendra M, Rittmann M, Wolf J. Zunehmende spastische Paraparese bei 38-jähriger Patientin aus Sierra Leone. DG Neurologie 2021; DOI 10.1007/s42451-020-00270-x

2. Wolf J. Neurologische Notfälle bei rheumatologischen Erkrankungen. Arthritis und Rheuma 2020; 40: 391-400; DOI 10.1055/a-1286-7407

3. Dorst J, Chen L, Rosenbohm A, Dreyhaupt J, Hübers A, Schuster J, Weishaupt JH, Kassubek J, Gess B, Meyer T, Weyen U, Hermann A, Winkler J, Grehl T, Hagenacker T, Lingor P, Koch JC, Sperfeld A, Petri S, Großkreutz J, Metelmann M, Wolf J, Winkler AS, Klopstock T, Boentert M, Johannesen S, Storch A, Schrank B, Zeller D, Liu XL, Tang L, Fan DS, Ludolph AC. Prognostic factors in ALS: a comparison between Germany and China. J Neurol 2019;266:1516-1525   

4. Müller K, Brenner D, Weydt P, …German ALS network MND-NET (u.a. Wolf J). Comprehensive analysis of the mutation spectrum in 301 German ALS families. J Neurol Neurosurg Psychiatry 2018;89:817-827   

5. Wolf J  Safer A, Maschke M, Nix WA, Wöhrle JC, Grau AJ. Epidemiologie der Amyotrophen Lateralsklerose: Daten aus dem ALS-Register Rheinland-Pfalz. Ärzteblatt Rheinland-Pfalz 2018;6:22-23  

6. Brenner D, Yilmaz R, Müller K, …German Network MND-Net (u.a. Wolf J). Hot-spot KIF5A mutations cause familial ALS. Brain 2018;141:688-697   

7. Funke A, Spittel S, Grehl T, Großkreutz J, Kettemann D, Petri S, Weyen U, Weydt P, Dorst J, Ludolph A, Baum P, Oberstadt M, Jordan B, Hermann A, Wolf J, Boentert M, Walter B, Gajewski N, Maier A, Münch C, Meyer T. Assistive technology devices in Amyotrophic Lateral Sclerosis - analysis of 4 years of platform-based case management. Amyotroph Lat Scler Frontotemp Degeneration 2018;19:342-350   

8. Van den Berg L, Van Damme P, Svenstrup K, Karlsborg M, Laaksovirta H, Salachas F, Corcia P, Couratier P, Desnuelle C, Grosskreutz J, Meyer T, Petri S, Koch JC, Weydt P, Wolf J,  Grehl T, Ludolph A, Hardiman O, Chiò A, Silani V, van der Kooi A, Holmøy T,  Kleveland G, Tysnes OB, Kuźma-Kozakiewicz M, de Carvalho M, Chandran S, Koritnik B, Mora J, Povedano M, Andersen P,  Mitre Ropero B, Nygren I, Staaf G, Ingre C, Danielsson O, Weber M, Shaw P, McDermott C, Talbot K, Al-Chalabi A. ENCALS statement on edaravone. Amyotroph Lat Scler Frontotemp Degeneration 2017;18:471-474   

9. Van Doormaal PC, Ticozzi N, Weishaupt JH, Kenna K, Diekstra FP, Verde F, Andersen PM, Dekker AM, Tiloca C, Marroquin N, Overste DJ, Pensato V, Nürnberg P, Pulit SL, Schellevis RD, Calini D, Altmüller J,  Francioli LC, Castellotti B, Motameny S, Ratti A, Wolf J, Gellera C, Ludolph AC, Van den Berg LH, Kubisch C, Landers JE, Veldink JH, Silani V, Volk AE. The role of de novo mutations in the development of amyotrophic lateral sclerosis. Human Mutation 2017:38:1534-1541   

10. Wolf J, Safer A, Wöhrle JC, Palm F, Nix WA, Maschke M, Grau AJ. Todesursachen bei Amyotropher Lateralsklerose: Ergebnisse aus dem ALS-Register Rheinland-Pfalz. Nervenarzt 2017;88:911-918   

11. Wolf J, Safer A. Amyotrophe Lateralsklerose: Was die ALS-Phänotypen für die Prognose bedeuten. Neurotransmitter 2017;28:29-32   

12. Wolf J. Sein härtester Kampf. Todesursachen bei der ALS. Ärzte-Woche 2017;16:4-5   

13. Wolf J,  Safer A, Wöhrle JC, Palm F, Nix WA, Maschke M, Grau AJ. Factors predicting survival in ALS patients - Data from a population-based registry in Rhineland-Palatinate, Germany. Neuroepidemiology 2015;44:149-155   

14. Dorst J, Dupuis L, Petri S, Kollewe K, Abdulla S, Wolf J, Weber M, et al. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study. J Neurol 2015; 262:849-58   

15. Wolf J, Safer A, Wöhrle JC, Palm F, Nix WA, Maschke M, Grau AJ. Factors predicting one-year mortality in amyotrophic lateral sclerosis patients - data from a population-based registry. BMC Neurology 2014;14:197  

16. Wolf J, Safer A, Wöhrle JC, Nix WA, Maschke M, Grau AJ. Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis - Data from a population-based registry. J Neurol Sci 2014;345:164-7   

17. Wolf J, Wöhrle JC, Palm F, Nix WA, Maschke M, Safer A, Becher H, Grau AJ. Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany. Amyotroph Lat Scler Frontotemp Degeneration 2014;15:269-74   

18. Palm F, Kraus M, Safer A, Wolf J, Chibuzor J, Becher H, Grau AJ. Management of oral anticoagulation after cardioembolic stroke and stroke survival data from a population based stroke registry (LuSSt). BMC Neurology 2014;14:199   

19. Urbanek C, Palm F, Buggle F, Wolf J, Safer A, Becher H, Grau AJ. Recent surgery or invasive procedures and the risk of stroke. Cerebrovasc Dis 2014;38:370-376   

20. Wolf J, Schmitt V, Palm F, Grau AJ, Bergner R. Peripheral neuropathy as initial manifestation of primary systemic vasculitides. J Neurol 2013;4:1061-70   

21. Palm F, Dos Santos M, Urbanek C, Greulich M, Zimmer K, Safer A, Grau AJ, Becher H. Stroke seasonality associations with subtype, etiology and laboratory results in the Ludwigshafen Stroke Study (LuSSt). Eur J Epidemiol 2013;28:373-81   

22. Palm F, Henschke N, Wolf J, Zimmer K, Safer A, Schröder RJ, Inselmann G, Brenk P,  Becher H, Grau AJ. Intracerebral hemorrhage in a population-based stroke registry (LuSSt) Incidence, aetiology, functional outcome and mortality. J Neurol 2013;260:2541-50   

23. Palm F, Kleemann T, Dos Santos M, Urbanek C, Buggle F, Safer A, Hennerici MG, Becher H, Zahn R, Grau AJ. Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study). CHADS(2), CHA(2)DS(2)-VASc score, underuse of oral anticoagulation, and implications for preventive measures. Eur J Neurol 2013;20:117-23   

24. Palm F, Urbanek Ch, Wolf J, Buggle F, Kleemann T, Hennerici MG, Inselmann G, Hagar M, Safer A, Becher H, Grau AJ. Etiology, risk factors and sex-differences in ischemic stroke in the Ludwigshafen Stroke Study (LuSSt), a population-based stroke registry. Cerebrovasc Dis 2012;33:69-75   

25. Wolf J, Obermaier-Kusser B, Jacobs M, Milles C, Mörl M, Müller H, Grau AJ, Bauer MF. A new mitochondrial point mutation in the transfer RNA (Lysine) gene causing a clinical phenotype of progressive external ophthalmoplegia with impaired respiratory regulation. J Neurol Sci 2012;316:108-111   

26. Dos Santos M, Grond-Ginsbach C, Aksay SS, Chen B, Tchatchou S, Wolf NI, van der Knaap MS, Grau AJ. Adult-onset autosomal dominant leukodystrophy due to LMNB1 gene duplication. J Neurol 2012;259:579-81   

27. Tomaschütz L, Dos Santos M, Schill J, Palm F, Grau A. Recurrent amaurosis fugax in a patient after stanford type a dissection depending on blood pressure and haemoglobin level. Case Rep Vasc Med 2012;2012:254204   

28. Wolf J, Bergner R, Mutallib S, Buggle F, Grau AJ. Neurologic complications of Churg-Strauss syndrome.  Eur J Neurol 2010;17:582-588   

29. Wolf J, Maschke M, Nix WA, Wöhrle JC, Grau AJ. Amyotrophe Lateralsklerose-Register: Startschuss für ein landesweit einzigartiges Projekt. Neurotransmitter 2010;4:16-17   

30. Martinez-Torres F, Menon S, Pritsch M, Victor N, Jenetzky E, Jensen K, Schielke E, Schmutzhard E, De Gans J, Chung CH, Luntz S, Hacke W, Meyding-Lamadé U, and GACHE Investigators (u.a. Wolf J). Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial. BMC Neurol 2008;8:40   

31. Wolf J, Jacobi C, Breer H, Grau A. Das Chediak-Higashi-Syndrom. Nervenarzt 2006;77:148-157   

32. Wolf J. Schlaganfälle im jungen Erwachsenenalter. Neurotransmitter 2006;6:64-70   

33. Wolf J, Niedermaier N, Lowitzsch K. Schlaganfälle im jungen Erwachsenenalter. Nervenheilkunde 2005;24:681-5   

34. Sartorius A, Wolf J, Henn F. Lithium and ECT - concurrent use still demands attention. World J Biol Psychiatry 2005;6:313-17   

35. Wolf J, Sartorius A, Alm B, Henn F. Clozapine-induced lupus erythematosus. J Clin Psychopharmacol 2004;24:236-8   

36. Wolf J, Niedermaier N, Bergner R, Lowitzsch K. Zerebrale Vaskulitis als Erstmanifestation eines systemischen Lupus erythematodes. Dtsch Med Wschr 2001;126:947-50

1. Wolf J, Grau A. Metabolische Hirnstammerkrankungen in: Erkrankungen des Hirnstamms, Herausgeber: Urban P., Schattauer-Verlag 2008, 290-310   

2. Wolf J, Grau A. Metabolic Brainstem Diseases in: Brainstem Disorders, Editors: Urban P, Caplan LR, Springer-Verlag 2011, 303-326  

1. Hambsch N, Tews B, Niggemann P, Wolf J. Beta-Amyloid-assoziierte Angiitis (ABRA). 93. Kongress der Dt. Gesellschaft für Neurologie, 05.11.2020, Berlin

2. Gaudlitz M, Spittel S, Weyen U, Grehl T, Grosskreutz J, Steinbach R, Weydt P, Günther R, Wolf J, Baum P, Metelmann M, Koch JC, Kettemann D, Norden J, George A, Koc Y, Walter B, Münch C, Maier A, Meyer T. Therapeutische Bewegungsgeräte bei der ALS: Anwendungshäufigkeit und subjektiver Nutzen in einer multizentrischen Beobachtungsstudie. 93. Kongress der Dt. Gesellschaft für Neurologie, 05.11.2020, Berlin

3. Schischlevskij P, Cordts I, Günther R, Zeller D, Schröter C, Weyen U, Regensburger M, Wurster CD, Wolf J, Schneider I, Hermann A, Metelmann M, Kohl Z, Koch JC, Kastrati K, Osmanovic A, Klopstock T, Boentert M, Lulé DE, Hagenacker T, Lingor P, Petri S, Schreiber-Katz O. Belastung pflegender Angehöriger von Patienten mit amyotropher Lateralsklerose (ALS) und anderen Motoneuronerkrankungen in Deutschland, 93. Kongress der Dt. Gesellschaft für Neurologie, 05.11.2020, Berlin

4. Wolf J. Vaskulitische Neuropathien - Neues zu Diagnostik und Therapie. 92. Kongress der Dt. Gesellschaft für Neurologie, Stuttgart, 25.09.2019   

5. Witzel S, Hübers A, Michels S, Petri S, Lingor P, Koch C, Hermann A, Günther R, Wolf J, Weishaupt JH, Otto M, Ludolph AC. Therapie mit Edaravone bei der amyotrophen Lateralsklerose. Kongress des medizinisch-wissenschaftlichen Beirats der Dt. Gesellschaft für Muskelkranke, Göttingen, 10.05.2019   

6. Wolf J, Safer A, Wöhrle JC, Palm F, Nix WA, Maschke M, Grau AJ.  Causes of death in amyotrophic lateral sclerosis. Results from the Rhineland-Palatinate ALS registry. Kongress des European Network to Cure ALS (ENCALS), 20.06.2018, Oxford/Großbritannien   

7. Wolf J. Epidemiologie der Amyotrophen Lateralsklerose in Deutschland. Festvortrag zur Verleihung des Christa-Lorenz-ALS-Forschungspreises, 13.12.2017, Universitätsklinikum Magdeburg   

8. Funke A, Spittel S, Grehl T, Großkreutz J, Kettemann D, Petri S, Weyen U, Weydt P, Dorst J, Ludolph A, Baum P, Oberstadt M, Jordan B, Hermann A, Wolf J, Boentert M, Walter B, Gajewski N, Maier A, Münch C, Meyer T. Assistive technology devices in Amyotrophic Lateral Sclerosis - analysis of 4 years of platform-based case management. International Symposium on ALS/MND. 07.12.2017, Boston/USA.   

9. Bajwa A, Rittmann M, Behrang-Nia M, Martins Dos Santos M, Homenu W, Becker H, Dorner M, Lücke T, Wolf J. Wundbotulismus - eine wichtige Differentialdiagnose bei Drogenabhängigen. Jahrestagung der Deutschen Gesellschaft für Neurointensiv- und Notfallmedizin (ANIM). 17.02.2017, Wien   

10. Alkhasova N, Rittmann M, Wolf J. Adulte Manifestation einer Mitochondrienmembranprotein-assoziierten Neurodegeneration. Kongress der Deutschen Gesellschaft für Neurologie. 22.09.2016, Mannheim   

11. Sharifzadeh Tadi A, Rittmann M, Wolf J. Late onset-Variante einer Globoidzell-Leukodystrophie (Morbus Krabbe) - Fallbericht. Kongress der Deutschen Gesellschaft für Neurologie. 22.09.2016, Mannheim  (Posterpreis der DGN)   

12. Wolf J. Aktuelle diagnostische und therapeutische Optionen bei vaskulitischen Neuropathien. Kongress der Deutschen Gesellschaft für Neurologie. 22.09.2016, Mannheim   

13. Wolf J, Safer A, Wöhrle J, Palm F, Nix W, Maschke M, Grau A. Prognosefaktoren bei Erstdiagnose einer Amyotrophen Lateralsklerose. Kongress des Wissenschaftlichen Beirates der Deutschen Gesellschaft für Muskelkranke. 18.06.2015, Bochum   

14. Wolf J, Safer A, Wöhrle J, Palm F, Nix W, Maschke M, Grau A. Prognostische Bedeutung unterschiedlicher ALS-Phänotypen. Kongress der Deutschen Gesellschaft für Neurologie. 25.09.2015, Düsseldorf   

15. Safer A, Palm F, Nix W, Maschke M, Wöhrle J, Grau AJ, Wolf J. Prognosefaktoren für das Überleben bei amyotropher Lateralsklerose - Daten aus dem ALS-Register Rheinland-Pfalz. Jahrestagung der Dt. Gesellschaft für Epidemiologie. 18.09.2014, Ulm   

16. Wolf J, Wöhrle J, Palm F, Nix W, Maschke M, Becher H, Grau A. Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany. International Symposium on ALS/MND. 07.12.2013, Mailand/Italien   

17. Wolf J, Wöhrle J, Palm F, Nix W, Maschke M, Becher H, Grau A. Epidemiologie der amyotrophen Lateralsklerose in Deutschland - das ALS-Register Rheinland-Pfalz. Kongress der Deutschen Gesellschaft für Neurologie. 20.09.2013, Dresden

• Reiser M, Borte M, Huscher D, Baumann U, Pittrow D, Sommer C, Stangel M, Fasshauer M, Gold R, Hensel M. Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long-term data of the SIGNS study. Eur J Haematol. 2017 Aug;99(2): 169-177.  
• Welz T, Wyen C, Hensel M. Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients. Oncol Res Treat. 2017;40(3):120-127. Review.
• Hentrich M, Hoffmann C, Mosthaf F, Müller M, Siehl J, Wyen C, Hensel M; German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ); German AIDS Society (DAIG). Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG). Ann Hematol. 2014 Jun;93(6):913-21. doi: 10.1007/s00277-014-2058-4. Epub 2014 Mar 29. Erratum in: Ann Hematol. 2014 Aug;93(8):1445.
• Hensel M, Brust J, Plöger C, Schuster D, Memmer ML, Franz-Werner J, Feustel HP, Karcher A, Fuxius S, Mosthaf FA, Rieger M, Ho AD, Witzens-Harig M.  Excellent long-term survival of 170 patients with Waldenström's macroglobulinemia treated in private oncology practices and a university hospital. Ann Hematol. 2012 Dec;91(12):1923-8.
• Hensel M, Goetzenich A, Lutz T, Stoehr A, Moll A, Rockstroh J, Hanhoff N, Jäger H, Mosthaf F. HIV and Cancer in Germany. Dtsch Arztebl Int. 2011 Feb;108(8):117-22. Epub 2011 Feb 25.
• Kornacker M, Kornacker B, Schmitt C, Leo E, Ho AD, Hensel M. Commercial LightCycler(R)-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma. Ann Hematol. 2009 Jan;88(1):43-50. Epub 2008 Jul 18.
• Hensel, M, Zoz M, Ho AD. Complementary and alternative medicine in patients with chronic lymphocytic leukemia. Support Care Cancer. 2009 Jan;17(1):47-52. Epub 2008 May 6.
• Schweizer C, Reu FJ, Ho AD, Hensel M. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.Ann Hematol. 2007 Oct;86(10):711-7. Epub 2007 Jul 11.
• Krämer A, Reiter A, Kruth J, Erben P, Hochhaus A, Müller M, Cross NC, Jones AV, Ho AD, Hensel M. JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia. Lancet Oncol. 2007 Jul;8(7):658-60. No abstract available.
• Hensel M, Dreger P, Ho AD. IgM-Gammopathie: Differentialdiagnose, Klinik und Therapie. Dtsch Arztebl 2007; 104(26): A-1907 / B-1684 / C-1620
• Hensel M, Zoz M, Giesecke C, Benner A, Neben K, Jauch A, Stilgenbauer S, Ho AD, Krämer A. High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia. Int J Cancer. 2007 Sep 1;121(5):978-83.
• Ho AD, Hensel M. Pentostatin and purine analogs for indolent lymphoid malignancies. Future Oncol. 2006 Apr;2(2):169-83. Review.
• Ho AD, Hensel M. Pentostatin for the treatment of indolent lymphoproliferative disorders. Semin Hematol. 2006 Apr;43(2 Suppl 2):S2-10. Review.
• Hensel M, Villalobos M, Kornacker M, Krasniqi F, Ho AD. Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma. Clin Lymphoma Myeloma. 2005 Sep;6(2):131-5.
• Hensel M, Buss EC, Tiemann M, Parwaresch R, Libicher M, Fruehauf S, Ho AD. Secondary follicular lymphoma of the bone, transformed into large cell lymphoma, in a patient with chronic lymphocytic leukaemia: an uncommon manifestation of Richter's syndrome. Eur J Haematol. 2004 Mar;72(3):217-21.
• Hensel M, Kornacker M, Yammeni S, Egerer G, Ho AD. Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.
• Br J Haematol. 2003 Aug;122(4):600-6. PMID: 12899715 [PubMed - indexed for
• Hensel M, Ho AD. Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab. Am J Hematol. 2003 May;73(1):37-40.
• Hensel M, Ho AD, Bastert G, Schneeweiss A. Prognostic markers for survival after high-dose chemotherapy with autologous stem-cell transplantation for breast cancer. Ann Oncol. 2003 Feb;14(2):341. No abstract available.
• Hensel M, Fiehn C, Ho AD. [Stem cell transplantation in primary systemic vasculitis] Med Klin (Munich). 2003 Jan 15;98(1):13-8. Review. German.
• Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R, Bastert G, Ho AD. P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support. Int J Cancer. 2002 Jul 20;100(3):290-6.
• Hensel M, Egerer G, Schneeweiss A, Goldschmidt H, Ho AD. Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncol. 2002 Feb;13(2):209-17.
• Hensel M, Schneeweiss A, Sinn HP, Egerer G, Kornacker M, Solomayer E, Haas R, Bastert G, Ho AD. Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support. Stem Cells. 2002;20(1):32-40.
• Schneeweiss A*, Hensel M*, Goerner R, Khbeis T, Hohaus S, Egerer G, Solomayer E, Haas R, Grischke EM, Bastert G, Ho AD. Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer. (*shared first author). Stem Cells. 2001;19(2):151-60.
• Hensel M, Breitbart A, Ho AD. Autologous hematopoietic stem-cell transplantation for Behçet's disease with pulmonary involvement. N Engl J Med. 2001 Jan 4;344(1):69. No abstract available

• Kriegsmann K, Rieger M, Schwarzbich MA, Sitter S, Kriegsmann M, Bruckner T, Hensel M, Ho AD, Witzens-Harig M, Wuchter P. Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma. Eur J Haematol. 2018 Jul;101(1):12-20.
• Reiser M, Dörfel S, Hensel M, Hoesl M, Jordan WO, Koenigsmann M, Meyer D, Reichert D, Schwarzer A, Marquardt M, Kellershohn K, Jentsch-Ullrich K. Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practice. Eur J Haematol. 2018 May;100(5):455-464.
• Dietrich S, Oleś M, Lu J, Sellner L, Anders S, Velten B, Wu B, Hüllein J, da Silva Liberio M, Walther T, Wagner L, Rabe S, Ghidelli-Disse S, Bantscheff M, Oleś AK, Słabicki M, Mock A, Oakes CC, Wang S, Oppermann S, Lukas M, Kim V, Sill M, Benner A, Jauch A, Sutton LA, Young E, Rosenquist R, Liu X, Jethwa A, Lee KS, Lewis J, Putzker K, Lutz C, Rossi D, Mokhir A, Oellerich T, Zirlik K, Herling M, Nguyen-Khac F, Plass C, Andersson E, Mustjoki S, von Kalle C, Ho AD, Hensel M, Dürig J, Ringshausen I, Zapatka M, Huber W, Zenz T. Drug-perturbation-based stratification of blood cancer. J Clin Invest. 2018 Jan 2;128(1)
• Kutsch N, Busch R, Bahlo J, Mayer J, Hensel M, Hopfinger G, Hess G, von Grünhagen U, Wendtner CM, Maria Fink A, Fischer K, Hallek M, Eichhorst B. FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2017 Feb;58(2):399-407.
• Stangel M, Gold R, Pittrow D, Baumann U, Borte M, Fasshauer M, Hensel M, Huscher D, Reiser M, Sommer C. Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry. Ther Adv Neurol Disord. 2016 May;9(3):165-79.
• Witzens-Harig M, Benner A, McClanahan F, Klemmer J, Brandt J, Brants E, Rieger M, Meissner J, Hensel M, Neben K, Dreger P, Lengfelder E, Schmidt-Wolf I, Krämer A, Ho AD. Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial. Br J Haematol. 2015 Dec;171(5):710-9.  
• Herth I, Hensel M, Rieger M, Horstmann K, Hiddemann W, Dreyling M, Koniczek S, Witzens-Harig M, Ho AD. Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemia. Leuk Lymphoma. 2015 Jan;56(1):97-102.
• Hoffmann C, Kohrs F, Sabranski M, Wolf E, Jaeger H, Wyen C, Siehl J, Baumgarten A, Hensel M, Jessen A, Schaaf B, Vogel M, Bogner J, Horst HA, Stephan C.  HIV-associated lung cancer: survival in an unselected cohort. Scand J Infect Dis. 2013 Oct;45(10):766-72.
• Fink AM, Böttcher S, Ritgen M, Fischer K, Pflug N, Eichhorst B, Wendtner CM, Winkler D, Bühler A, Zenz T, Staib P, Mayer J, Hensel M, Hopfinger G, Wenger M, Fingerle-Rowson G, Döhner H, Kneba M, Stilgenbauer S, Busch R, Hallek M. Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.Leukemia. 2013 Sep;27(9):1949-52. Free PMC Article
• Martin Stangel, Ulrich Baumann, Michael Borte, Maria Fasshauer, Manfred Hensel, Dörte Huscher, Wilhelm Kirch, David Pittrow, Marcel Reiser, Ralf Gold. Treatment of Neurological Autoimmune Diseases With Immunoglobulins: First Insights From the Prospective SIGNS Registry. Martin Stangel, Ulrich Baumann, Michael Borte. J Clin Immunol. 2013 Jan;33 Suppl 1:S67-71.
• McClanahan F, Hielscher T, Rieger M, Hensel M, Bentz M, Schmidt-Wolf I, Käbisch A, Salwender H, Dürk H, Staiger H, Mandel T, Neben K, Hillengass J, Leo E, Krämer A, Ho AD, Witzens-Harig.  Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma. Am J Hematol. 2012 Jun 8. doi: 10.1002/ajh.23286. [Epub ahead of print]
• McClanahan F, Hielscher T, Rieger M, Hensel M, Bentz M, Schmidt-Wolf I, Käbisch A, Salwender H, Dürk H, Staiger H, Mandel T, Neben K, Hillengass J, Leo E, Krämer A, Ho AD, Witzens-Harig M. Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma. Am J Hematol. 2012 Jun 8. doi: 10.1002/ajh.23286. [Epub ahead of print] No abstract available.
• Dreger P, Döhner H, McClanahan F, Busch R, Ritgen M, Greinix H, Fink AM, Knauf W, Stadler M, Pfreundschuh M, Dührsen U, Brittinger G, Hensel M, Schetelig J, Winkler D, Bühler A, Kneba M, Schmitz N, Hallek M, Stilgenbauer S. Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the GCLLSG CLL3 trial. Blood. 2012 Apr 5. [Epub ahead of print]
• Borte M, Baumann U, Pittrow D, Hensel M, Fasshauer M, Huscher D, Reiser M, Stangel M, Gold R, Kirch W; Liste der aktuell beitragenden Zentren, sortiert nach Postleitzahlen (mindestens ein Patient zum 1.3.2012). [Immunoglobulins in PID, SID and neurological autoimmune disease]. Dtsch Med Wochenschr. 2012 Mar;137(13):675-80. Epub 2012 Mar 20. Review. German.
• Witzens-Harig M, Hensel M, Unterhalt M, Herfarth K.Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial.BMC Cancer. 2011 Feb 26;11:87.
• Kornacker M, Stumm J, Pott C, Dietrich S, Süssmilch S, Hensel M, Nickelsen M, Witzens-Harig M, Kneba M, Schmitz N, Ho AD, Dreger P.Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up. Ann Oncol. 2009 Apr;20(4):722-8. Epub 2009 Jan 29.
• Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J, Hensel M, Hopfinger G, Hess G, von Grünhagen U, Bergmann M, Catalano J, Zinzani PL, Caligaris-Cappio F, Seymour JF, Berrebi A, Jäger U, Cazin B, Trneny M, Westermann A, Wendtner CM, Eichhorst BF, Staib P, Bühler A, Winkler D, Zenz T, Böttcher S, Ritgen M, Mendila M, Kneba M, Döhner H, Stilgenbauer S; International Group of Investigators; German Chronic Lymphocytic Leukaemia Study Group.Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.Lancet. 2010 Oct 2;376(9747):1164-74.
• Kirch W, Gold R, Hensel M, Fasshauer M, Pittrow D, Huscher D, Reiser M, Stangel M, Baumann U, Borte M. Assessment of immunoglobulins in a long-term non-interventional study (SIGNS Study). Rationale, design, and methods. Med Klin (Munich). 2010 Sep;105(9):647-51. Epub 2010 Sep 28. German.
• Zenz T, Eichhorst B, Busch R, Denzel T, Häbe S, Winkler D, Bühler A, Edelmann J, Bergmann M, Hopfinger G, Hensel M, Hallek M, Döhner H, Stilgenbauer S. TP53 mutation and survival in chronic lymphocytic leukemia.J Clin Oncol. 2010 Oct 10;28(29):4473-9. Epub 2010 Aug 9.
• McClanahan F, Hielscher T, Rieger M, Hensel M, Neben K, Hillengass J, Herfarth K, Ho AD, Witzens-Harig M. Clinical outcome of patients with follicular lymphoma and bulky disease after rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy.Eur J Haematol. 2010 Jul;85(1):11-9. Epub 2010 Mar 16.
• Stilgenbauer S, Zenz T, Winkler D, Bühler A, Schlenk RF, Groner S, Busch R, Hensel M, Dührsen U, Finke J, Dreger P, Jäger U, Lengfelder E, Hohloch K, Söling U, Schlag R, Kneba M, Hallek M, Döhner H; German Chronic Lymphocytic Leukemia Study Group.Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group.J Clin Oncol. 2009 Aug 20;27(24):3994-4001. Epub 2009 Jul 13.
• Kornacker M, Stumm J, Pott C, Dietrich S, Süssmilch S, Hensel M, Nickelsen M, Witzens-Harig M, Kneba M, Schmitz N, Ho AD, Dreger P. Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up.Ann Oncol. 2009 Apr;20(4):722-8. Epub 2009 Jan 29.
• Witzens-Harig M, Reiz M, Heiß C, Benner A, Hensel M, Neben K, Dreger P, Kraemer A, Ho AD. Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial. Ann Hematol. 2009 Jan;88(1):51-7. Epub 2008 Jul 30.
• Zwick C, Birkmann J, Peter N, Bodenstein H, Fuchs R, Hänel M, Reiser M, Hensel M, Clemens M, Zeynalova S, Ziepert M, Pfreundschuh M; German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL).Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone).Ann Hematol. 2008 Sep;87(9):717-26. Epub 2008 Jun 28.
• Haas J, Schopp L, Storch-Hagenlocher B, Fritzsching B, Jacobi C, Milkova L, Fritz B, Schwarz A, Suri-Payer E, Hensel M, Wildemann B. Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis.Blood. 2008 Jan 15;111(2):761-6. Epub 2007 Oct 29.
• Dreger P, Rieger M, Seyfarth B, Hensel M, Kneba M, Ho AD, Schmitz N, Pott C. Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome. Haematologica. 2007 Jan;92(1):42-9.
• Witzens-Harig M, Heilmann C, Hensel M, Kornacker M, Benner A, Haas R, Fruehauf S, Ho AD. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.Stem Cells. 2007 Jan;25(1):228-35.
• Mey UJ, Olivieri A, Orlopp KS, Rabe C, Strehl JW, Gorschlueter M, Hensel M, Flieger D, Glasmacher AG, Schmidt-Wolf IG. DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis. Leuk Lymphoma. 2006 Dec;47(12):2558-66.
• Mey UJ, Orlopp KS, Flieger D, Strehl JW, Ho AD, Hensel M, Bopp C, Gorschlüter M, Wilhelm M, Birkmann J, Kaiser U, Neubauer A, Florschütz A, Rabe C, Hahn C, Glasmacher AG, Schmidt-Wolf IG. Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.Cancer Invest. 2006 Oct;24(6):593-600.
• Schlenk RF, Frohling S, Hartmann F, Fischer JT, Glasmacher A, Del Valle F, Gotze K, Nerl C, Schoch R, Pralle H, Mergenthaler HG, Hensel M, Koller E, Kirchen H, Matzdorff A, Salwender H, Biedermann HG, Kremers S, Haase D, Benner A, Dohner K, Dohner H. Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial. Leukemia. 2006 Apr;20(4):748-50.
• Kornacker M, Moldenhauer G, Herbst M, Weilguni E, Tita-Nwa F, Harter C, Hensel M, Ho AD. Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma.Int J Cancer. 2006 Sep 15;119(6):1377-82.
• Eichhorst BF, Busch R, Hopfinger G, Pasold R, Hensel M, Steinbrecher C, Siehl S, Jaeger U, Bergmann M, Stilgenbauer S, Schweighofer C, Wendtner CM, Doehner H, Brittinger G, Emmerich B, Hallek M. Fludarabine plus cyclophosphamide versus fludarabine alone in first line therapy of younger patients with chronic lymphocytic leukemia.Blood. 2006 Feb 1;107(3):885-91. Epub 2005 Oct 11.
• Schmitt C, Grundt A, Buchholtz C, Scheuer L, Benner A, Hensel M, Ho AD, Leo E. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?Leuk Res. 2006 Dec;30(12):1563-8. Epub 2006 Mar 10.
• Schmitt C, Balogh B, Grundt A, Buchholtz C, Leo A, Benner A, Hensel M, Ho AD, Leo E. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.Leuk Res. 2006 Jun;30(6):745-50. Epub 2005 Nov 16.
• Maurer B, Hensel M, Max R, Fiehn C, Ho AD, Lorenz HM. Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up.Ann Rheum Dis. 2006 Jan;65(1):127-9. Epub 2005 May 26.
• Nikendei C, Schilling T, Nawroth P, Hensel M, Ho AD, Schwenger V, Zeier M, Herzog W, Schellberg D, Katus HA, Dengler T, Stremmel W, Müller M, Jünger J. [Integrated skills laboratory concept for undergraduate training in internal medicine]. Dtsch Med Wochenschr. 2005 May 6;130(18):1133-8. German.
• Schlenk RF, Germing U, Hartmann F, Glasmacher A, Fischer JT, Del Valle Y Fuentes F, Gotze K, Pralle H, Nerl C, Salwender H, Grimminger W, Petzer A, Hensel M, Benner A, Zick L, Dohner K, Frohling S, Dohner H. High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia. 2005 Jun;19(6):978-83.
• Bochtler T, Hensel M, Lorenz HM, Ho AD, Mahlknecht U. Chronic lymphocytic leukaemia and concomitant relapsing polychondritis: a report on one treatment for the combined manifestation of two diseases.Rheumatology (Oxford). 2005 Sep;44(9):1199. Epub 2005 Apr 26.
• Schneeweiss A, Diel I, Hensel M, Kaul S, Sinn HP, Unnebrink K, Rudlowski C, Lauschner I, Schuetz F, Egerer G, Haas R, Ho AD, Bastert G. Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy.Ann Oncol. 2004 Nov;15(11):1627-32.
• Reusch U, Le Gall F, Hensel M, Moldenhauer G, Ho AD, Little M, Kipriyanov SM. Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells.Int J Cancer. 2004 Nov 10;112(3):509-18.
• Mechtersheimer G, Egerer G, Hensel M, Rieker RJ, Libicher M, Lehnert T, Penzel R. Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib. Virchows Arch. 2004 Feb;444(2):108-18. Epub 2004 Jan 20. Review.
• Schetelig J, Thiede C, Bornhauser M, Schwerdtfeger R, Kiehl M, Beyer J, Sayer HG, Kroger N, Hensel M, Scheffold C, Held TK, Hoffken K, Ho AD, Kienast J, Neubauer A, Zander AR, Fauser AA, Ehninger G, Siegert W; Cooperative German Transplant Study Group.
• Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.J Clin Oncol. 2003 Jul 15;21(14):2747-53.
• Schlenk RF, Benner A, Hartmann F, del Valle F, Weber C, Pralle H, Fischer JT, Gunzer U, Pezzutto A, Weber W, Grimminger W, Preiss J, Hensel M, Frohling S, Dohner K, Haas R, Dohner H; AML Study Group Ulm (AMLSG ULM). Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial. Leukemia. 2003 Aug;17(8):1521-8.
• Schetelig J, Thiede C, Bornhäuser M, Schwerdtfeger R, Kiehl M, Beyer J, Kröger N, Hensel M, Scheffold C, Ho AD, Kienast J, Neubauer A, Zander AR, Fauser AA, Ehninger G, Siegert W. Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.Ann Hematol. 2002;81 Suppl 2:S47-8.
• Schulz H, Klein SK, Rehwald U, Reiser M, Hinke A, Knauf WU, Aulitzky WE, Hensel M, Herold M, Huhn D, Hallek M, Diehl V, Engert A; German CLL Study Group. Phase-II Study of a combined Immuno-Chemotherapy using Rituximab and Fludarabine in Patients With Chronic Lymphocytic Leukemia Blood 2002 Nov 1;100(9):3115-20
• Egerer G, Goldschmidt H, Hensel M, Harter C, Schneeweiss A, Ehrhard I, Bastert G, Ho AD. Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation.Bone Marrow Transplant. 2002 Oct;30(7):427-31.
• Schneeweiss A, Hensel M, Sinn P, Khbeis T, Haas R, Bastert G, Ho AD. Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose.Ann Oncol. 2002 May;13(5):679-88.
• Egerer G, Hensel M, Ho AD. Infectious complications in chronic lymphoid malignancy.Curr Treat Options Oncol. 2001 Jun;2(3):237-44. Review.
• Schlenk RF, Hartmann F, Hensel M, Jung W, Weber-Nordt R, Gabler A, Haas R, Ho AD, Trümper L, Döhner H. Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.Leukemia. 2002 Apr;16(4):581-6.
• Perz J, Topaly J, Fruehauf S, Hensel M, Ho AD. Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia.Leuk Lymphoma. 2002 Jan;43(1):149-51.
• Schneeweiss A, Goerner R, Hensel M, Lauschner I, Sinn P, Kaul S, Egerer G, Beldermann F, Geberth M, Solomayer E, Grischke EM, Haas R, Ho AD, Bastert G. Tandem high-dose chemotherapy in high-risk primary breast cancer: a multivariate analysis and a matched-pair comparison with standard-dose chemotherapy.Biol Blood Marrow Transplant. 2001;7(6):332-42.

• Hensel M., Witzens-Harig M.: Niedrigmaligene Non-Hodgkin-Lymphome beim alten und geriatrischen Patienten. In: Geriatrische Onkologie. Hrsg.: Ebert, Härtel, Wedding. Springer Verlag 2018
• Hensel M.: Multiple Myeloma and Monoclonal Gammopathy of Unknown Significance. In: HIV-associated Hematological Malignancies. Hrsg.: Hentrich, Barta. Springer Verlag 2017
• Hensel M. Chemotherapeutika und Anästhesie. In: Anästhesie in der Traumatologie und Orthopädie. Hrsg.: Th. Frietsch, A. Weiler-Lorentz. Urban&Fischer Verlag, München 2009
• Hinkelbein J, Feller-Heppt G, Lenz C, Hensel M, Frietsch T. Mastozytose: Pathologie und anästhesiologische Implikationen für die Praxis. 2008
• Hensel M. Einsatz monoklonaler Antikörper bei malignen Lymphomen (Rituximab, Zevalin/Bexxar, Epratuzumab, HuMax-CD20, Galiximab). In: Antikörpertherapie in der Hämatologie und Onkologie. UNI-MED Verlag Bremen. 2007
• Hensel M. Substitution von Immunglobulinen. In: Supportivtherapie bei malignen Erkrankungen. Herausgeber: Link; Bokemeyer, Feyer. Deutscher Ärzteverlag Köln, 2006
• Fiehn C, Hensel M. High Dose Chemotherapy with Haematopoietic Stem Cell Transplantation in Primary Systemic Vasculitis, Behcet`s disease and Sjoegren`s Syndrome. Stem Cell Therapy for Autoimmune Disease. eds. Marmont and Burt; Landes Bioscience, Georgetown, USA. 2003

Publikationsverzeichnis von Prof. Dr. Kai-Uwe Köhrmann:

• Risks in healthcare: recognize, avoid, assess 
  Köhrmann KU.
  Urologe A. 2018 Jul;57(7):783-784. doi: 10.1007/s00120-018-0694-3. German. No abstract available.

• Focal therapy of prostate cancer
  Ganzer R, Franiel T, Köllermann J, Kuru T, Baumunk D, Blana A, Hadaschik B, von Hardenberg J, Henkel T, Köhrmann KU, Liehr UB, Machtens S, Roosen A, Salomon G, Schlemmer HP, Sentker L, Wendler J, Witzsch U, Schostak M. 
  Urologe A. 2017 Oct;56(10):1335-1346. doi: 10.1007/s00120-017-0488-z. German.

• MRI/TRUS fusion-guided prostate biopsy : Value in the context of focal therapy
  Franz T, von Hardenberg J, Blana A, Cash H, Baumunk D, Salomon G, Hadaschik B, Henkel T, Herrmann J, Kahmann F, Köhrmann KU, Köllermann J, Kruck S, Liehr UB, Machtens S, Peters I, Radtke JP, Roosen A, Schlemmer HP, Sentker L, Wendler JJ, Witzsch U, Stolzenburg JU, Schostak M, Ganzer R. 
  Urologe A. 2017 Feb;56(2):208-216. doi: 10.1007/s00120-016-0268-1. Review. German.

• Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage. 
  Wendler JJ, Ganzer R, Hadaschik B, Blana A, Henkel T, Köhrmann KU, Machtens S, Roosen A, Salomon G, Sentker L, Witzsch U, Schlemmer HP, Baumunk D, Köllermann J, Schostak M, Liehr UB.
  World J Urol. 2017 Jan;35(1):11-20. doi: 10.1007/s00345-016-1838-y. Epub 2016 May 4. Review
  
  
• Focal therapy for small renal masses : Observation, ablation or surgery
  Wendler JJ, Friebe B, Baumunk D, Blana A, Franiel T, Ganzer R, Hadaschik B, Henkel T, Köhrmann KU, Köllermann J, Kuru T, Machtens S, Roosen A, Salomon G, Schlemmer HP, Sentker L, Witzsch U, Liehr UB, Ricke J, Schostak M. 
  Urologe A. 2016 May;55(5):594-606. doi: 10.1007/s00120-016-0075-8. Review. German.